 Clinical Investigation  Plan Cover Page  
 
 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
87173 CIP Posting Cover Page Ver B  
Template  Page 1 of 39 
 
 
 
Study ID: [REMOVED]  
DELIVERY  
EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial 
(DELIVERY)  
Study Document No: SJM-CIP-10116  
Version [ C] 
Date: 4 October, 2019  
 
 
 
Sponsor    Abbott  
           The Corporate Village  
                                                    Da Vincilaan 11 -boxF1  
          1935 Zaventem, Belgium  
 
Abbott  
    6901 Preston Road  
    Plano, TX USA 75024  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 2 of 39 
                                             [REDACTED]   
 
 
 
DELIVERY  
Randomized, Controlle D, Single Blind, ProspEctive, Mu LtIcenter Study E Valuating Anatomic v Ersus 
TaRgeted Lead Placement for BurstDR Therap Y During the Trial Evaluation Period.  
CRD_ 767 
Study Document No: SJM-CIP-10116  
Version  [C] 
Date: 21-JUN-2017  
Clinical Investigation Plan (CIP)  
 
 
Sponsor    Abbott  
           The Corporate Village  
                                                    Da Vincilaan 11 -boxF1  
          1935 Zaventem, Belgium  
                                                     
Abbott  
    6901 Preston Road  
    Plano, TX USA 75024  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 3 of 39 
                                             [REDACTED]   
 
 
PRINCIPAL INVESTIGATOR SIGNATURE PAGE  
 
 
 
 
I have read and agree to adhere  to the clinical investigation  plan and all regulatory requirements 
applicable in conducting this clinical investigation . 
 
 
Principal Investigator  
 
Printed name:  
Signature:  
Date:  
 
 
  
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

7DEOHRI&RQWHQWV

 ,QWURGXFWLRQ    
 %DFNJURXQGDQG-XVWLILFDWLRQIRU&OLQLFDO,QYHVWLJDWLRQ   
 'HYLFHV8QGHU,QYHVWLJDWLRQ    
 ,GHQWLILFDWLRQDQG'HVFULSWLRQRI WKH'HYLFHVXQGHULQYHVWLJDWL RQ  
  ,GHQWLILFDWLRQ    
  'HYLFH'HVFULSWLRQDQG,QWHQGHG3XUSRVH   
  'HYLFH+DQGOLQJDQG6WRUDJH   
 'HYLFHV$FFRXQWDELOLW\    
 &OLQLFDO,QYHVWLJDWLRQ'HVLJQ    
 &OLQLFDO,QYHVWLJDWLRQ'HVLJQ    
 2EMHFWLYHV    
  3ULPDU\2EMHFWLYH   
  6HFRQGDU\2EMHFWLYH   
 (QGSRLQWV    
  3ULPDU\(QGSRLQW   
  6HFRQGDU\(QGSRLQW   
  'HVFULSWLYH(QGSRLQWV   
 6WXG\3RSXODWLRQ   
  ,QFOXVLRQ&ULWHULD   
  ([FOXVLRQ&ULWHULD    
 3URFHGXUHV    
 ,QIRUPHG&RQVHQW3URFHVV   
 6FUHHQLQJ    
 3RLQWRI(QUROOPHQW   
 6FKHGXOHG3URFHGXUHV   
  (QUROOPHQW%DVHOLQH9LVLW   
  5DQGRPL]DWLRQDQG%OLQGLQJ   
  7ULDO6\VWHP,PSODQW,QLWLDO7ULDO(YDOXDWLRQ3HULRG6WDUW   
  (QGRI,QLWLDO7ULDO(YDOXDWLRQ9LVLW   
  (QGRI([WHQGHG7ULDO(YDOXDWLRQ3HULRGLIDSSOLFDEOH   
 8QVFKHGXOHG9LVLWV   
 3DWLHQW5HSRUWHG2XWFRPH352PHDVXUHV   
  1XPHULFDO5DWLQJ6FDOH156   
  3DWLHQW5HSRUWHG3DLQUHOLHI353    
  ,WHP$GXOW6FDOHRIWKH3DWLHQW5HSRUWHG2XWFRPHV0HDVXUHPHQ W,QIRUPDWLRQ6\VWHP
3520,6'H\R5DPVD\%XFNOH\HWDO   
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

  3DLQ&DWDVWURSKL]LQJ6FDOH3&6 6XOOLYDQ%LVKRS	3LYLN   
  6WLPXODWLRQ$VVHVVPHQW   
 &OLQLFLDQ$VVHVVPHQWV   
 'HVFULSWLRQRI$FWLYLWLHV3HUIRU PHGE\6SRQVRU5HSUHVHQWDWLYHV   
 6XEMHFW6WXG\&RPSOHWLRQ   
 6XEMHFW:LWKGUDZDO   
 6WXG\&RPPLWWHHV   
  6WHHULQJ&RPPLWWHH6&   
 6WDWLVWLFDO&RQVLGHUDWLRQV    
 +\SRWKHVHV    
  3ULPDU\(QGSRLQW+\SRWKHVLV   
  6HFRQGDU\(QGSRLQW+\SRWKHVLV   
 -XVWLILFDWLRQRI&OLQLFDO,QYHVWLJDWLRQ'HVLJQ   
 0XOWLSOLFLW\    
 2YHUDOO6DPSOH6L]H   
 'HVFULSWLYH(QGSRLQWV   
 7LPLQJRI$QDO\VLV   
 6XFFHVV&ULWHULD   
 ,QWHULP$QDO\VLV   
 6WDWLVWLFDO&ULWHULDIRU7HUPLQDWLRQ   
 'HYLDWLRQVIURP6WDWLVWLFDO3ODQ   
 5LVNVDQG%HQHILWV    
 5LVNV$VVRFLDWHGZLWKWKH'HY LFH8QGHU,QYHVWLJDWLRQ   
  $QWLFLSDWHG$GYHUVH'HYLFH(IIHFWV   
  5LVNV$VVRFLDWHGZLWK&OLQLFDO ,QYHVWLJDWLRQ$VVHVVPHQWV   
 5LVN&RQWURO0HDVXUHV   
 3RVVLEOHLQWHUDFWLRQVZLWKFRQFRPLWDQWWUHDWPHQWV   
 5LVNWR%HQHILW5DWLRQDOH   
 5HTXLUHPHQWVIRU,QYHVWLJDWRU5HFRUGVDQG5HSRUWV   
 'HYLDWLRQVIURP&,3   
 6DIHW\5HSRUWLQJ   
  &RPSODLQWV'HYLFH'HILFLHQFLHV   
 6RXUFHUHFRUGV   
 5HFRUGV5HWHQWLRQ   
 &OLQLFDO'DWD+DQGOLQJ    
 3URWHFWLRQRI3HUVRQDOO\,GHQWLILDEOH,QIRUPDWLRQ   
 'DWD0DQDJHPHQW3ODQ   
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 'RFXPHQWDQG'DWD&RQWURO   
  7UDFHDELOLW\RI'RFXPHQWVDQG'DWD   
  5HFRUGLQJ'DWD    
 0RQLWRULQJ    
 &RPSOLDQFH6WDWHPHQW   
 6WDWHPHQWRI&RPSOLDQFH   
 4XDOLW\$VVXUDQFH$XGLWVDQG5HJXODWRU\,QVSHFWLRQV   
 5HSHDWHGDQG6HULRXV1RQ&RPSOLDQFH   
 6XVSHQVLRQRU3UHPDWXUH7HUPLQDWL RQRIWKH&OLQLFDO,QYHVWLJDWL RQ  
 &OLQLFDO,QYHVWLJDWLRQ&RQFOXVLRQ   
 3XEOLFDWLRQ3ROLF\    
 5HSRUWLQJ5HVXOWVRQ&OLQFDO7ULDOVJRY:HEVLWH   
 $SSHQGL[$&,35HYLVLRQV   
 $SSHQGL[%'HILQLWLRQV   
 $SSHQGL[&%XUVW'53URJUDPPLQJ*XLGHOLQHV   
 $SSHQGL[',PDJLQJ*XLGHOLQHV   
 $SSHQGL[(%LEOLRJUDSK\   
 $SSHQGL[)&DVH5HSRUW)RUP    
 $SSHQGL[*,QIRUPHG&RQVHQW)RUP   


 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 7 of 39 
                                             [REDACTED]   
 
1 Introduction  
This document is a clinical investigation plan (CIP) for the clinical investigation of the SJMâ„¢ Invisible Trial 
System  with market -approved lead (s). This clinical investigation is intended to evaluate anatomic versus 
targeted lead placement for BurstDR â„¢ therapy during the trial evaluation period . 
 
This clinical investigation is sponsored by Abbott (A BT). 
 
This clinical investigation will be conducted in accordance with this CIP. All parties involved in the conduct 
of the clinical investigation will be qualified by education, training, or experience to perform their tasks and 
this training will be docu mented appropriately.  
2 Background  and Justification  for Clinical Investigation  
Spinal cord stimulation (SCS) reduces pain and improves function and quality of life  for patients with  
chronic, intractable pain1. Typically, patients , who are candidates for SCS have failed other treatment 
options , are recommended by their physician to participate in a SCS trial evaluation period with 
percutaneously implanted leads powered by an external generator. The trial evaluation period can span 
from 3 to 30 days (or more) depending on the patient needs, physicianâ€™s discretion, and regional 
reimbursement requirements. Successful trial evaluation of the SCS device is contingent upon adequate 
pain relief and/or functional improvements as assessed by the patient and the physici an. Standard of care 
for â€œsuccessfulâ€ trial evaluations is driven by reimbursement in most countries, which typically includes, but 
may not be limited to, patient assessment of 50% pain relief and willingness to proceed to a permanent 
implantable pulse gen erator (IPG).  
 
Until recently, SCS trials and permanent systems delivered tonic stimulation (See Figure 1), which delivers 
a stream of pulses at consistent amplitude, pulse width and frequency. Tonic stimulation produces 
paresthesia, a tingling sensation,  in the areas of stimulation coverage. Outcomes during the trial evaluation 
are thought to predict long -term success with therapy, though evidence in the literature is sparse due to 
poor reporting of trial experiences. Rates of successful trial evaluations  leading to permanent implant vary 
in the literature (41% to 71% or more).2,3 
 
Recently, BurstDRâ„¢ stimulation mode was approved in Europe and the US for use in permanently 
implanted systems (CE mark: March 2014 and PMA: October 2016). BurstDR â„¢ programmable parameters 
include (A) the burst train, (B) the time of onset of the burst train to the time of onset of the next burst train 
(burst rate), and (C) the rate of pulses within each train (intra -burst rate) (See Figure 2). While BurstDRâ„¢ 
featur es a group of pulses that are repeated in an on/off pattern, it is unlike cycle mode because it mimics 
the natural signaling of burst neurons utilizing closely spaced stimuli. The amplitudes used for BurstDRâ„¢ 
stimulation are reported to be significantly lo wer than those traditionally used for tonic stimulation which 
results in pain suppression that is generally sensation free  (e.g., does not produce paresthesia) . 
 
The St. Jude Medicalâ„¢ Invisible Trial System, capable of delivering both tonic and BurstDRâ„¢ st imulation, 
was approved (CE mark: June 2015 and PMA : July 2015). The Invisible Trial System consists of an External 
Pulse Generator (EPG) and a Patient Controller. The EPG is smaller than other systems on the market and 
is designed to be bandaged to the pa tientâ€™s back, which eliminat es access to connector wires to reduce 
dislodgement and lead migrations . Furthermore, the EPG is controlled wirelessly via Bluetoothâ„¢ low 
energy technology with the Patient Controller.  
 
Lead placement for BurstDRâ„¢ has proceeded  to use temporary tonic stimulation such that the sensory 
qualities of tonic programming (paresthesias) can be used to elicit feedback from patients and  ensure the 
leads are properly placed and programmed. Because BurstDRâ„¢ results in sensation -free therapy  for most 
patients, it has been proposed that anatomic placement of the leads could result in effective therapy while 
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

UHGXFLQJSURFHGXUHWLPHVGXULQJERWKWKHWULDOHYDOXDWLRQDQGS HUPDQHQWV\VWHPLPSODQWV1RVWXGLHVKDYH
LQYHVWLJDWHGWKLVSURFHGXUDOYDULDWLRQWRGDWH

$GGLWLRQDOO\WKHUHLVQRSXEOLVKHGOLWHUDWXUHIRUWKHXVHRI% XUVW'5ÂŒRUWKH,QYLVLEOH7ULDO6\VWHPGXULQJ
WKHWULDOHYDOXDWLRQSHULRGDQGWKXVQRTXDQWLWDWLYHH[DPLQD WLRQRIWKHUDWHRIVXFFHV VIXOTXDOLILFDWLRQIRU
SHUPDQHQWLPSODQWZKHQWKLVWKHUD S\PRGHDQGGHYLFHLVXVHGGXU LQJWKHWULDOHYDOXDWLRQSHULRG
7KHUHIRUHWKHDLPVRIWKHSURSRVH GFOLQLFDOLQYHV WLJDWLRQDUH WRHYDOXDWHWKHTXDOLILFDWLRQUDWHRI%XUVW'5ÂŒ
LQFRQMXQFWLRQZLWKWKH,QYLVLEOH7ULDO6\VWHPGXULQJWKHWULDO HYDOXDWLRQSHULRGIRU%XUVW'5ÂŒWKHUDS\YLD
DQDWRPLFYHUVXVWDUJHWHGOHDGSODFHPHQW
)LJXUHWRQLFSDWWHUQ



)LJXUH%XUVW'5ÂŒSDWWHUQ


 'HYLFHV8QGHU,QYHVWLJDWLRQ
 ,GHQWLILFDWLRQDQG'HVFULSWLRQ RIWKH'HYLFHVXQGHULQYHVWLJDW LRQ
 ,GHQWLILFDWLRQ

,QWKLVFOLQLFDOLQYHVWLJDWLRQWKH6-0ÂŒ,QYLVLEOH7ULDO6\VWHP LVEHLQJXVHGDQGFRQVLVWVRIDQ([WHUQDO
3XOVH*HQHUDWRU(3*D&OLQLFLDQ3URJUDPPHUDQGD3DWLHQW&RQ WUROOHU7KHFRPSRQHQWVFRPPXQLFDWH
ZLWKHDFKRWKHUYLD ZLUHOHVV%OXHWRRWKÂŒFRPPXQLFDWLRQ



 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

7DEOH,GHQWLILFDWLRQRI'HYLFHVXQGHU,QYHVWLJDWLRQ

'HYLFHQDPH  0RGHO7\SH 0DQXIDFWXUHU 5HJLRQ&RXQWU\ ,QYHVWLJDWLRQDORU
0DUNHW5HOHDVHG
6-070,QYLVLEOH7ULDO
6\VWHP 6-0(0($$1=&$86 0DUNHW5HOHDVHG
&OLQLFLDQ
3URJUDPPHU 
L3DG0LQL
6-0 (0($$1=&$86 0DUNHW5HOHDVHG
3DWLHQW&RQWUROOHU
L3RG7RXFK  
6-0 (0($$1=&$86 0DUNHW5HOHDVHG

 'HYLFH'HVFULSWLRQDQG,QWHQGHG3XUSRVH
7KH6-0ÂŒ,QYLVLEOH7ULDO6\VWHP LVLQGLFDWHGIRUXVHLQVXEMHFW VDVDQDLGLQWKHPDQDJHPHQWRIFKURQLF
LQWUDFWDEOHSDLQRIWKHWUXQNDQGRUOLPEVDQGLVXVHGGXULQJW KHWULDOV\VWHPHYDOXDWLRQSHULRG,WFRQVLVWV
RIDQ([WHUQDO3XOVH*HQHUDWRU(3*D&OLQLFLDQ3URJUDPPHUDQ GD3DWLHQW&RQWUROOHU7KHFRPSRQHQWV
FRPPXQLFDWHZLWKHDFKRWKHUYLDZ LUHOHVV%OXHWRRWKÂŒ/RZ(QHUJ\ %/(FRPPXQLFDWLRQ
 'HYLFH+DQGOLQJDQG6WRUDJH
7KHGHYLFHVXVHGGXULQJWKLVF OLQLFDOLQYHVWLJDWLRQDUHFRPPHUF LDOO\DYDLODEOHDQGZLOOEHKDQGOHGDQG
VWRUHGDFFRUGLQJWRWKHDSSOLFDEOH SURGXFWPDQXDOVDQGVWDQGDUG VLWHSUDFWLFHV
 'HYLFHV$FFRXQWDELOLW\
7KHGHYLFHVXVHGGXULQJWKLVF OLQLFDOLQYHVWLJDWLRQDUHFRPPHUF LDOO\DYDLODEOHDQGGHY LFHDFFRXQWDELOLW\LV
QRWUHTXLUHG
 &OLQLFDO,QYHVWLJDWLRQ'HVLJQ
 &OLQLFDO,QYHVWLJDWLRQ'HVLJQ
7KLVLVDUDQGRPL]HGFRQWUROOHGVLQJOHEOLQGPXOWLFHQWHUFO LQLFDOLQYHVWLJDWLRQF RPSDULQJVXFFHVVUDWHV
IRUDQDWRPLFDOO\SODFHGOHDGV WRFRQYHQWLRQDOWDUJHWHGOHDGSO DFHPHQWIRU%XUVW'5ÂŒGXULQJWKHWULDO
HYDOXDWLRQSHULRGZLWKWKH6-0ÂŒ,QYLVLEOH7ULDO6\VWHP6XEMHFW VZLOOEHEOLQGHGWRWUHDWPHQWJURXSDQG
UDQGRPL]HGLQDUDWLRDVIROORZV
x *URXS$%DQDWRPLFOHDGS ODFHPHQWIROORZHGE\%XUVW'5ÂŒVWL PXODWLRQGXULQJDQLQLWLDOWULDO
HYDOXDWLRQSHULRG
x *URXS7%WDUJHWHGOHDGSODFHPHQWIROORZHGE\%XUVW'5ÂŒVWL PXODWLRQGXULQJDQLQLWLDOWULDO
HYDOXDWLRQSHULRG
,IWKHVXEMHFWTXDOLILHVIRUSHUPDQHQWV\VWHPLPSODQWDVGHILQH GLQVHFWLRQDIWHUWKHLQLWLDOWULDO
HYDOXDWLRQSHULRGWKHVXEMHFWZLOOH[LWWKHFOLQLFDOLQYHVWLJD WLRQDQGFRQWLQXHWKHLUWUHDWPHQWSHUWKH
SK\VLFLDQÂ¶VVWDQGDUGRIFDUH6XEMHFWVZKRGRQRWTXDOLI\IRUS HUPDQHQWV\VWHPLPSODQWDVGHILQHGLQ
VHFWLRQDIWHUWKHLQLWLDOWULDOHYDOXDWLRQSHULRGPD\SD UWLFLSDWHLQDQH[WHQGHGWULDOHYDOXDWLRQSHULRG
SHUSK\VLFLDQGLVFUHWLRQGXULQJZKLFKWKH\ZLOOEHSURJUDPPHG ZLWKWRQLFVWLPXODWLRQ6XEMHFWVFRQWLQXLQJ
WRDQH[WHQGHGWULDOHYDOXDWLRQSHULRGZLOOEHIROORZHGWKURXJK WKHFRPSOHWLRQRIWKHH[WHQGHGWULDOSHULRG
$WWKHHQGRIWKHH[WHQGHGWULDO HYDOXDWLRQSHULRGVXEMHFWVZL OOH[LWWKHFOLQLFDOLQYHVWLJDWLRQ

 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 10 of 39 
                                             [REDACTED]   
 
End of Extended Trial 
PeriodExtended Trial PeriodEnd of Initial Trial Period
Qualify for Permanent 
Implant?Initial Trial PeriodRandomization (1:1)Enrollment/
Baseline
Anatomical Lead 
Placement (AB)
BurstDRTMfor 3 -
5 Days
Yes
Exit StudyNo
Tonic 
Stimulation for 
additional min .3 
days (optional)
Exit StudyTargeted Lead 
Placement (TB)
BurstDRTMfor 3 -
5 Days
Yes
Exit StudyNo
Tonic 
Stimulation for 
additional min. 3 
days (optional)
Exit StudyThe randomization diagram (Figure 3) and  the study flow chart  (Figure 4) are shown below.  
 
Figure 3: Randomization Diagram  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Study Flow Chart   
Initial Trial 
Evaluation  
(all subjects)  
RANDOMIZATION  
Group 1 
(AB) 
BurstDR â„¢ 
stimulation  
Anatomic 
Lead 
Group 2  
(tB) 
BurstDR â„¢ 
stimulation  
Targeted 
Lead 
Extended  Trial 
Evaluation   
(if applicable)  
Tonic stimulation  
Tonic stimulation  
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

$SSUR[LPDWHO\VXEM HFWVZLOOEHHQUROOHGDWXSWRVLWHVL QWKH(0($$1=&$DQG86UHJLRQV
6XEMHFWVSDUWLFLSDWLQJLQWKLVF OLQLFDOLQYHVWLJDWLRQZLOOEHI ROORZHGIRUWKHGXUDWLRQRIWKHLUWULDOHYDOXDWLRQ
SHULRGRQO\(QUROOPHQWLQWKLVFOLQLFDOLQYHVWLJDWLRQLVDQWLF LSDWHGWRODVWDSSUR[LPDWHO\PRQWKV7KHWRWDO
GXUDWLRQRIWKHFOLQLFDOLQYHVWLJDWLRQLVH[SHFWHGWREHDSSUR[ LPDWHO\PRQWKV
 2EMHFWLYHV
 3ULPDU\2EMHFWLYH
7KHSULPDU\REMHFWLYHLQWKLVFOLQ LFDOLQYHVWLJDWLRQLVWRGHPR QVWUDWHWKDWWKHTXDOLILFDWLRQUDWHZLWKDQDWRPLF
OHDGSODFHPHQWLVQRQLQIHULRUWRWKHTXDOLILFDWLRQUDWHZLWKW DUJHWHGOHDGSODFHPHQWWRQLFSDUHVWKHVLD
JXLGHGIRUWKH%XUVW'570VWLPXODWLRQWULDOHYDOXDWLRQSHULRG
 6HFRQGDU\2EMHFWLYH
7KHVHFRQGDU\REMHFWLYHRIWKLVFOLQLFDOLQYHVWLJDWLRQLVWRHV WDEOLVKDKLJKHUUDWHR ISK\VLFLDQSUHIHUHQFH
IRUDQDWRPLFOHDGSODFHPHQWSURFHGXUH
 (QGSRLQWV
7KHUHLVRQHSULPDU\HQGSRLQWDQGRQHVHFRQGDU\HQGSRLQWLQWKL VFOLQLFDOLQYHVWLJDWLRQ
 3ULPDU\(QGSRLQW
7KHSULPDU\HQGSRLQWLVWKHTXDOLILFDWLRQUDWHIRUSHUPDQHQWV\ VWHPLPSODQWDWWKHHQGRIWKHLQLWLDOWULDO
HYDOXDWLRQSHULRG4XDOLILFDWLRQIRUSHUPDQHQWV\VWHPLPSODQWLVGHILQHGE\DFRPS RVLWHLQZKLFKDVXEMHFWPHHWVDOORIWKH
IROORZLQJFRQGLWLRQV
Â‡ !SDWLHQWUHSRUWHGSDLQUHO LHI353DWWKHHQGRIWKHWUL DOHYDOXDWLRQ
Â‡ 7ULDOHYDOXDWLRQSHULRGODVWHGIRUDPLQLPXPRIGD\VÂ‡ 3K\VLFLDQUHFRPPHQGVVXEMHFWIRUSHUPDQHQWV\VWHPLPSODQWÂ‡ 6XEMHFWUHSRUWVDZLOOLQJQHVV WRSXUVXHDSHUPDQHQWV\VWHPLP SODQW
6XEMHFWVDUHQRWTXDOLILHGIRUSHUPDQHQWV\VWHPLPSODQWLIWKH\ PHHWERWKRIWKHIROORZLQJ
Â‡ Â”353SDWLHQWUHSRUWHGSDL QUHOLHIDWWKHHQGRIWKHWUL DOHYDOXDWLRQ
Â‡ 7ULDOHYDOXDWLRQSHULRGODVWHGIRUDPLQLPXPRIGD\V
 6HFRQGDU\(QGSRLQW
7KHVHFRQGDU\HQGSRLQWLVWKHU DWHRISK\VLFLDQSUHIHUHQFHIRU DQDWRPLFSODFHPHQWYHUVXVWDUJHWHG
SODFHPHQWDWWKHHQGRIWKHVWXG\
 'HVFULSWLYH(QGSRLQWV
'HVFULSWLYHHQGSRLQWVDUHUHSRUWHGXVLQJRQO\VXPPDU\VWDWLVWLF VDQGQRK\SRWKHVLVWHVWVZLOOEHSHUIRUPHG

 2YHUDOOSURFHGXUHWLPHLQURRPWRRXWURRPLPSODQWSURFHG XUHWLPHQHHGOHLQWRQHHGOHRXW
DQGWRWDOWLPHRILQWUDRSHUDWLYHIOXRURVFRS\H[SRVXUHIRUHDFK UDQGRPL]HGJURXSDQGVWUDWLILHGE\
QXPEHURIOHDGVDQGOHDGW\SHS HUPDQHQWOHDGRUWHPSRUDU\OHDG 
 3URJUDPPLQJWLPHUHTXLUHGIRUHDFKUDQGRPL]HGJURXS &KDQJHIURPSUHLPSODQW1XPHULFDO5DWLQJ6FDOH156LQHDFK UDQGRPL]HGJURXSWRHQGRILQLWLDO
WULDOHYDOXDWLRQSHULRGDQGWRW KHHQGRIWKHH[WHQGHGWULDOHY DOXDWLRQSHULRGDVDSSOLFDEOH
 1XPEHURIVXEMHFWVLQHDFKUDQGRPL]HGJURXSZKRKDYHDIILUPD WLYHDVVHVVPHQWIRUHDFKRIWKH
LQGHSHQGHQWFULWHULDUHTXLUH GIRUTXDOLILFDWLRQIRUSHUPDQHQWL PSODQW
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 3URSRUWLRQRIVXEMHFWVLQHDFKUDQGRPL]HGJURXSZKRGRQRWT XDOLI\IRUSHUPDQHQWLPSODQW
KRZHYHUGRSURFHHGZLWKSHUPDQHQWLPSODQWSHUSK\VLFLDQGLVFUHW LRQ
 7LPHIURPWULDOV\VWHPLPSODQWWR!353PHDVXUHGE\WKHQ XPEHURIGD\VDOVRNQRZQDV
Â³ZDVKLQSHULRGÂ´
 5DWHRIVHULRXVDGYHUVHGHYLFHHIIHFWV6$'(LQHDFKJURXS 
 1XPEHUDQGSURSRUWLRQRIPHDQL QJIXOOHDGPLJUDWLRQV
GXULQJ WKHLQLWLDOWULDOHYDOXDWLRQSHULRGVE\
WUHDWPHQWJURXS
 1XPEHUDQGSURSRUWLRQRIPHDQL QJIXOOHDGPLJUDWLRQV
GXULQJ WKHLQLWLDOWULDOHYDOXDWLRQSHULRGLQ
VXEMHFWVZKRKDYHDWHPSRUDU\WULDOOHDGLPSODQWFRPSDUHGWRVX EMHFWVZKRKDYHDSHUPDQHQWWULDO
OHDGLPSODQW
&OLQLFLDQDVVHVVPHQWRIDQ HVWKHVLDUHODWHGGLIILFXOW\DVVH VVHGSULPDULO\LQWKHSURFHGXUHURRPIRU
WKHWULDORQDSRLQWOLNHUWVFDOHIRUHDFKUDQGRPL]HGJURXS 
&OLQLFLDQDVVHVVPHQWRIOHDG SODFHPHQWGLIILFXOW\RQDSR LQWOLNHUWVFDOHIRUHDFKUDQGRPL]HG
JURXS
&OLQLFLDQDIILQLW\OLNLQJIRUOHDGSODFHPHQWWHFKQLTXHDW WKHHQGRIWKHWULDOLPSODQWSURFHGXUH
3HUPDQHQWV\VWHPTXDOLILFDWLRQUDWHDWWKHHQGRIH[WHQGHG WULDOSHULRG


$PHDQLQJIXOOHDGPLJUDWLRQLVGHILQHGDVDOHDGPLJUDWLRQUHV XOWLQJLQWKHLQDELOLW\WRSURJUDPIRUWKHUDSHXWLF
UHVSRQVH
 6WXG\3RSXODWLRQ
7KHLQWHQGHGSRSXODWLRQIRUWKLVFOLQLFDOLQYHVWLJDWLRQLVSDWL HQWVRYHUWKHDJHRI\HDUVWKDWKDYHFKURQLF
LQWUDFWDEOHSDLQRIWKHWUXQNDQG RUORZHUOLPEVDQGKDYHEHHQ UHFRPPHQGHGE\DSK\VLFLDQIRUVSLQDOFRUG
VWLPXODWLRQWKHUDS\
 ,QFOXVLRQ&ULWHULD
7RSDUWLFLSDWHLQWKLVFOLQLFDO LQYHVWLJDWLRQWKHSDWLHQWPXVW PHHWDOORIWKHIROORZLQJ LQFOXVLRQFULWHULD

 3DWLHQWLQGLFDWHGIRU6&6WKH UDS\LQDFFRUGDQFHZLWKWKHDSS URYHGODEHOLQJ
 3DWLHQWÂ¶VSDLQSURILOHLQGLF DWHVDSSURSULDWHOHDGSODFHPHQW ZRXOGEHDWRQHRUPRUHOHYHOVIURP
7WR7WRDFKLHYHSDLQFRYHUDJH
 3DWLHQWKDVDEDVHOLQHVFRU HRQWKH156Â•RYHUWKHSDVW KRXUVIRUÂµDYHUDJHRYHUDOOSDLQÂ¶
VSHFLILFWRWKHDUHDVRIFKURQLF SDLQWKDWZLOOEHWUHDWHGZL WKVSLQDOFRUGVWLPXODWLRQ
 3DWLHQWLVFRQVLGHUHGE\WKH6WXG\,QYHVWLJDWRUDVDFDQGLGD WHIRULPSODQWDWLRQRIDVSLQDOFRUG
VWLPXODWRUV\VWHPDFFRUGLQJWRW KHV\VWHP,QVWUXFWLRQVIRU8VH 
 3DWLHQWLV!\HDUVRIDJ HDWWKHWLPHRIHQUROOPHQW
 3DWLHQWLVZLOOLQJWRDGKHUH WRWKHVWXG\UHTXLUHPHQWVLQFO XGLQJFRPSOLDQFHZLWKDQGFRPSOHWLRQ
RIDOOVWXG\YLVLWV
 3DWLHQWKDVVLJQHGDQGUHF HLYHGDFRS\RIWKH(&,5%DSSURYH GLQIRUPHGFRQVHQW
 ([FOXVLRQ&ULWHULD
3DWLHQWVDUHQRWHOLJLEOHIRUFOLQ LFDOLQYHVWLJDWLRQSDUWLFLSDW LRQLIWKH\PHHWDQ\RIWKHIROORZLQJH[FOXVLRQ
FULWHULD
 3DWLHQWFXUUHQWO\KDVDVSLQDOFRUGVWLPXODWLRQV\VWHPLPSOD QWHG
 3DWLHQWKDVSUHYLRXVO\IDLOHGDVSLQDOFRUGVWLPXODWLRQWKHU DS\HLWKHUWULDOV\VWHPHYDOXDWLRQRU
SHUPDQHQWV\VWHPLPSODQW

3DWLHQWKDVDSULPDU\GLDJQRVLVRI3HULSKHUDO9DVFXODU'LVHDVH 39'$QJLQD3HFWRULVRU
&KURQLF0LJUDLQH
 3DWLHQWLVVFKHGXOHGWRXQGHUJRDQRQWKHWDEOHWULDOHYDOXD WLRQDNDDOOLQRQHSURFHGXUH
 3DWLHQWLVVFKHGXOHGWREHLP SODQWHGZLWKDVXUJLFDOSDGGO HWULDOOHDGV
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 3DWLHQWLVFXUUHQWO\SDUWLFLSDWLQJLQDQRWKHUFOLQLFDOLQYHV WLJDWLRQZLWKDQDFWLYHWUHDWPHQWDUP
 3DWLHQWLVXQDEOHWRUHDGDQGRUZULWH
 3URFHGXUHV
$SSURYDOIURPWKH6SRQVRUPXVWE HUHFHLYHGSULRUWRLQLWLDWLQJ VWXG\SURFHGXUHV
3DWLHQWVDUHFRQVLGHUHGHQUROOHGLQWKHVWXG\DQGEHFRPHVXEMHF WVIURPWKHPRPHQWWKHSDWLHQWVKDYH
SURYLGHGZULWWHQ3DWLHQW,QIRUPHG&RQVHQW(QUROOHGVXEMHFWVZLOOEHUDQGRPL]HGEHIRUHDQ\VWXG\SURFHGXUH LVSHUIRUPHG6XEMHFWVZLOOXQGHUJRDWULDO
V\VWHPLPSODQWSURFHGXUHZLWKOHDGSODFHPHQWDFFRUGLQJWRWKHLU UDQGRPL]DWLRQJURXS)ROORZXSRI
VXEMHFWVZLOOEHDFFRUGLQJWRWKHVLWHÂ¶VSUDFWLFH8SRQFRPSOHW LRQRIWKHLQLWLDOWULDOHYDOXDWLRQSHULRGWKH
VXEMHFWZLOOEHFRQVLGHUHGWRKDYHFRPSOHWHGWKHVWXG\LIKHVK HTXDOLILHVIRUSHUPDQHQWLPSODQW,QFDVH
WKHVXEMHFWGRHVQRWTXDOLI\I RUSHUPDQHQWLPSODQWWKHWULDOH YDOXDWLRQSHULRGPD\EHH[WHQGHGSHU
SK\VLFLDQGLVFUHWLRQ7KHH[WHQGH GWULDOHYDOXDWLRQSHULRGZLOO FRQWLQXHIRUDQDGGLWLRQDOPLQLPXPRIGD\V
DQGZLOOHQGSHUVWDQGDUGRIFDUH6XEMHFWVZKRGRQRWFKRRVH WRHQWHUWKHH[WHQGHGWULDOHYDOXDWLRQSHULRG
ZLOOH[LWWKHVWXG\7KH3ULQFLSDO,QYHVWLJDWRUVKR XOGDUUDQJHIRUDSSURSULDWHFDUH RIVXEMHFWVIROORZLQJVWXG\FRPSOHWLRQ
7KH3ULQFLSDO,QYHVWLJDWRULVU HVSRQVLEOHIRUHQVXULQJDOOFOLQ LFDOLQYHVWLJDWLRQGDWD DUHFROOHFWHGDVUHTXLUHG
SHU&,3VFKHGXOHGSURFHGXUHV7KHIROORZLQJVHFWLRQVSURYLG HDGHWDLOHGGHVFULSWLRQRISURFHG XUHVUHTXLUHGE\WKLV&,3
 ,QIRUPHG&RQVHQW3URFHVV
7KH3ULQFLSDO,QYHVWLJDWRURUKLVKHUDXWKRUL]HGGHVLJQHHZLOO FRQGXFWWKH,QIRUPHG&RQVHQW3URFHVVDV
UHTXLUHGE\DSSOLFDEOHUHJXODWLRQVDQGWKHFHQWHUÂ¶V,5%(&7KL VSURFHVVZLOOLQFOXGHDYHUEDOGLVFXVVLRQ
ZLWKWKHVXEMHFWRQDOODVSHFWVRIWKHFOLQLFDOLQYHVWLJDWLRQW KDWDUHUHOHYDQWWRWKHVXEMHFWÂ¶VGHFLVLRQWR
SDUWLFLSDWHVXFKDVGHWDLOVRI FOLQLFDOLQYHVWLJDWLRQSURFHGXU HVDQWLFLSDWHGEHQHILWVDQGSRWHQWLDOULVNVRI
FOLQLFDOLQYHVWL JDWLRQSDUWLFLSDWLRQ'XULQJWKHGLVFXVVLRQWK H3ULQFLSDO,QYHVWLJDWRURUKLVKHUDXWKRUL]HG
GHVLJQHHZLOODYRLGDQ\LPSURSHULQIOXHQFHRQWKHVXEMHFWDQGZ LOOUHVSHFWVXEMHFWÂ¶VOHJDOULJKWV7KHVXEMHFW
VKDOOEHSURYLGHGZLWKWKHLQIRUPHGFRQVHQWIRUPZULWWHQLQDO DQJXDJHWKDWLVXQGHUVWDQGDEOHWRWKHVXEMHFW
DQGKDVEHHQDSSURYHGE\WKHFH QWHUÂ¶V,5%(&7KHVXEMHFWVKDOO KDYHDGHTXDWHWLPHWRUHYLHZDVN
TXHVWLRQVDQGFRQVLGHUSDUWLFLSDWLRQ,IWKHVXEMHFWDJUHHVWRSDUWLFL SDWHWKH,QIRUPHG&RQVHQWIRUP PXVWEHVLJQHGDQGGDWHGE\WKHVXEMHFW
DQGE\WKHSHUVRQREWDLQLQJWKHFRQVHQW7KHVLJQHGRULJLQDOZL OOEHILOHGLQWKHVXEMHFWÂ¶VKRVSLWDORUUHVHDUFK
FKDUWVDQGDFRS\ZLOOEHSURYLGHGWRWKHVXEMHFW7KH3ULQFLSDO,QYHVWLJDWRURUKLVKHUDXWKRUL]HGGHVLJQHHZLOO GRFXPHQWWKHLQIRUPHGFRQVHQWSURFHVVLQ
WKHVXEMHFWÂ¶VKRVSLWDODQGRUUHVHDUFKFKDUWV7KHGDWHRIVLJQ DWXUHZLOOEHHQWHUHGRQDQDSSOLFDEOH&DVH
5HSRUW)RUP&5))DLOXUHWRREWDLQLQIRUPHGFRQVHQWIURPDVXEMHFWSULRUWRFOLQ LFDOLQYHVWLJDWLRQHQUROOPHQWVKRXOGEHUHSRUWHG
WR6SRQVRUZLWKLQZRUNLQJGD\VDQGWRWKHUHYLHZLQJFHQWHUÂ¶V ,5%(&DFFRUGLQJWRWKH,5%Â¶V(&Â¶V
UHSRUWLQJUHTXLUHPHQWV,IGXULQJWKHFOLQLFDOLQYHVWLJDWLRQQHZLQIRUPDWLRQEHFRPHV DYDLODEOHWKDWFDQVLJQLILFDQWO\DIIHFWD
VXEMHFW
VIXWXUHKHDOWKDQGPHGLFDOFDUHWKH3ULQFLSDO,QYHVWL JDWRURUKLVKHUDXWKRUL]HGGHVLJQHHZLOO
SURYLGHWKLVLQIRUPDWLRQWRWKHVXEMHFW,IUHOHYDQWWKHVXEMH FWZLOOEHDVNHGWRFRQILUPWKHLUFRQWLQXLQJ
LQIRUPHGFRQVHQWLQZULWLQJ
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 6FUHHQLQJ
7KH3ULQFLSDO,QYHVWLJDWRURUGHOHJDWHGVWXG\SHUVRQQHOLVUHVS RQVLEOHIRUVFUHHQLQJDOOSRWHQWLDOSDWLHQWVWR
GHWHUPLQHSDWLHQWHOLJLELOLW\ IRUWKHFOLQLFDOL QYHVWLJDWLRQ
,IDSDWLHQWPHHWVDOOLQFOXVLR QFULWHULDDQGGRHVQRWPHHWDQ\ RIWKHH[FOXVLRQFULWHUL DKHVKHLVHOLJLEOHIRU
WKHFOLQLFDOLQYHVWLJDWLRQ5HFRUGVRISDWLHQWVZKRDUHVFUHHQHGPXVWEHPDLQWDLQHG,QFDVHWKHVXEMHFWGRHVQRWPHHWDOOLQFOXVLRQFULWHULDRUPHH WVDQ\RIWKHH[FOXVLRQ FULWHULDWKHVXEMHFWLV
FRQVLGHUHGDVFUHHQLQJIDLOXUH7KH3ULQFLSDO,QYHVWLJDWRURUW KHGHOHJDWHGVWXG\SHUVRQQHOZLOOUHFRUGWKH
VFUHHQLQJIDLOXUHLQWKHKRVSLWD OUHFRUGVDQGRQDVFUHHQLQJOR JDVUHTXLUHG
 3RLQWRI(QUROOPHQW
3DWLHQWVDUHFRQVLGHUHGHQUROOHG LQWKHFOLQLFDOL QYHVWLJDWLRQ DQGEHFRPHVXEMHFWVIURPWKHPRPHQWWKH
SDWLHQWVKDYHSURYLGHGZUL WWHQ3DWLHQW,QIRUPHG&RQVHQW

7KH3ULQFLSDO,QYHVWLJDWRURUGHOHJDWHGVWXG\SHUVRQQHOZLOOUH FRUGHQUROOPHQWLQIRUPDWLRQQDPHRIWKH
FOLQLFDOLQYHVWL JDWLRQGDWHRIFRQVHQW DQG,QFOXVLRQH[FOXVLRQ LQIRUPDWLRQLQWKHKRVSLWDOUHFRUGVDQG
FRPSOHWHDQGVXEPLWDQDSSOLFD EOH&5)LQDWLPHO\PDQQHU
1RWLILFDWLRQRIHQUROOPHQWWRWKH6SRQVRULVFRQVLGHUHGWRKDYH RFFXUUHGZKHQWKH6SRQVRUKDVUHFHLYHG
WKHDSSOLFDEOH&5)
 6FKHGXOHG3URFHGXUHV
7KH3ULQFLSDO,QYHVWLJDWRULVU HVSRQVLEOHIRUHQVXULQJDOOFOLQ LFDOLQYHVWLJDWLRQGDWD DUHFROOHFWHGDVUHTXLUHG
SHU&,3VFKHGXOHGSURFHGXUHV7KHOLVWRIFOLQLFDOL QYHVWLJDWLRQVSHFLIL FWHVWVDQGSURFHGXUH V7DEOHEHORZVXPPDUL]HYLVLWIORZDQG
UHTXLUHPHQWVRIWKLVFOLQLFDOLQYHVWLJDWLRQ
7DEOH/LVWRIDOOFOLQLFDOLQYHVWLJDWLRQVSHFLILFWHVWVDQG SURFHGXUHV



9LVLW











6WXG\$FWLYLW\ 
(QUROOPHQW%DVHOLQH
7ULDO6\VWHP,PSODQW
,QLWLDO7ULDO(YD OXDWLRQ3HULRG
6WDUW
(QGRI,QLWLDO7ULDO(YDOXDWLRQ
3HULRG
%HJLQ([WHQGHG7ULDO(YDOXDWLRQ
,IDSSOLFDEOH
(QGRI([WHQGHG7ULDO(YDOXDWLRQ
3HULRGLIDSSOLFDEOH
8QVFKHGXOHG9LVLW
,QIRUPHG&RQVHQW ;    
6XEMHFW(OLJLELOLW\ ;    
'HPRJUDSKLFV3DLQ+LVWRU\	
'LDJQRVLV;    
1XPHULFDO5DWLQJ6FDOH ;  ; ; 
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 15 of 39 
                                             [REDACTED]   
 
PROMIS -29 X     
Pain Catastrophizing Scale  X     
Patient satisfaction and PR P   X (X)  
Randomization  X (X)    
Implant procedure and system data   X    
Patient  Trial Diary   X X (X)  
Email Programming Details   X X (X) (X) 
Stimulation Assessment   X X (X) (X) 
Qualify for permanent implant    X (X)  
Reason for Visit      X 
Procedure Time   X    
Programming Time   X   (X) 
Subjectâ€™s Feedback    X   
Clinician Assessment   X    
Physicianâ€™s Preference    X*   
Imaging   X X (X) (X) 
Lead Location   X X (X) (X) 
SADEs,  SAEs  ADEs    (X) (X) (X) (X) 
Deviation(s)  (X) (X) (X) (X) (X) 
Withdrawal  (X) (X) (X) (X) (X) 
Death  (X) (X) (X) (X) (X) 
 
(X) If applicable  
* only after last subjectâ€™s last End of Initial Trial Period Visit - for a single site  
5.4.1 Enrollment/ Baseline  Visit 
The following assessments and information will be collected at the baseline visit : 
â€¢ Demographics, pain history, pain diagnosis  
â€¢ Numerical Rating Scale (NRS)  
â€¢ Patient Reported Outcomes Measurement Information System -29 (PROMIS -29) 
â€¢ Pain Catastrophizing Scale (PCS)  
â€¢ Deviations (if applicable)  
â€¢ Withdrawal (if applicable)  
â€¢ Death (if applicable)  
5.4.2 Randomization  and Blinding  
Randomization may occur at the end of the baseline visit or just prior to surgery for t rial system implant 
(Initial Trial Evaluation Period Start) Visit.   
 
Subjects will be randomized (1:1) using random permuted blocks of varying length and stratified by site . 
Subjects will be  blinded to treatment group and treated in two groups as follows : 
 
1. Group 1 (AB): anatomic lead placement followed by BurstDRâ„¢ stimulation during initial trial 
evaluation period  
2. Group 2 (TB): targeted lead placement follow ed by BurstDRâ„¢ stimulation during initial trial 
evaluation period  
  
Randomization assignment will be communicated to the site via the Randomization Application available 
in the EDC Site Portal.  
 
Regardless of sedation, s ubjects will not be able to distingu ish what implant technique (anatomic or 
targeted) is utilized without intimate knowledge of SCS programming, and with standardizing subject  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 16 of 39 
                                             [REDACTED]   
 
interactions, the subjects will remain  blinded to the treatment group. Implanting physicians and surgical 
support staff must follow the specific guidelines for the lead placement techniques and therefore cannot be 
blinded, but will be provided with a standardized script to assist with subject  interaction as a  way to minimize 
the risk of disclosing randomization assignments.  Additionally, sites will be instructed to schedule study 
visits to restrict study subjects from being in the clinic at the same time , which aims to minimize subject to 
subject communication . Prior to study exit and before being unblinded, subjects will be asked about their 
memory for intra -operative testing as an assessment of the blind. Intra -operative testing is the key 
distinguishing feature between the techniques, so assessment of memory  for experience will help to 
establish the status of the blind for each subject .   
 
A Blinding Plan will be maintained separately which will include a listing of all parties involved in the study 
to manage workflow and identification of blinded and unblind ed information.   
5.4.3 Trial System Implant (Initial Trial Evaluation Period Start)  
Record the required information on the applicable  CRF: 
â€¢ Implant procedure and system data  
â€¢ Stimulation assessment  
â€¢ Clinician assessment  
â€¢ Procedur e time 
â€¢ Programming time  
â€¢ Adverse events (if applicable)  
â€¢ Deviations (if applicable)  
â€¢ Withdrawal (if applicable)  
â€¢ Death (if applicable)  
 
Upload and attach the following documentation to the applicable CRF:  
â€¢ Images  
 
Device programming session records will be emailed directly to Abbott from the  Clinician Programmer by 
Abbott personnel or designee in xml format to the following email address:  CDOUpload@sjm.com . 
 
The subject will complete a Patient Trial Diary once a day utilizing an application located on the Patient 
Controller during the trial evaluation period.  The subject will record areas of pain, stimulation therapy goals 
and percentage of pain relief in the  diary.  At the end of the trial evaluation period, the End of Trial Summary 
report will be submitted  to the sponsor.  
 
The following section of the protocol provides a guideline for surgical implantation and programming of the 
trial evaluation system.  
 
Lead Placement  Technique : 
 
Anatomic lead placement  (Randomiz ation Group 1)  
 
Physicians may implant one or two leads as per their preference/standard of care at the site. Guidance for 
placement of the leads is provided below:  
 
Placement of 1 lead : 
 
â–ª Lead 1 â€“ Place lead tip at the rostral end of T8 segment  
â–ª No tonic mapping/confirmation required  
â–ª Confirm position using fluoroscopy (X -ray) and reposition lead if needed  
 
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 17 of 39 
                                             [REDACTED]   
 
Placement of 2 leads:  
 
â–ª Lead 1 â€“ Place lead tip at the rostral end of T8 segment  
â–ª Lead 2 â€“ Place lead tip at the rostral end of T9 segment  
â–ª No tonic mapping/confirmation required  
â–ª Confirm position using fluoroscopy (X -ray) and reposition lead if needed  
 
Targeted Lead Placement Technique (Randomization Group 2)  
 
â–ª Physicians may implant one or two leads as  per their preference/standard of care at the site  
â–ª Utilize the standard lead placement technique as per standard of care for BurstDR stimulation .  
â–ª Position lead(s) at the appropriate thoracic segment in the epidural space â€“ dictated by pain 
coverage requir ed by patient  
â–ª Confirm adequate coverage of pain areas using tonic stimulation  
â–ª Adjust lead position as needed to attain adequate coverage of pain areas  
 
Refer to Appe ndix D e.g. x -ray, fluoroscopy for additional requirements regarding imaging at the end of the 
lead placement procedure.   
 
Anchoring  Technique : 
Securing the SCS leads during this investigation is critical to evaluate the anatomic versus targeted lead 
placement through the course of the trial period .  Acceptable methods to secure the leads include suturing 
and utilization of anchors. Methods that are not allowed during this investigation include include steri -strips 
and pre -manufactured bandages.   
 
Postoperative Programming : 
After the trial system implant procedure is complete, all subjects will be programmed with Burst DRâ„¢ 
stimulation programs by trained personnel and/or a n Abbott  representative using the Clinician Programmer . 
Subjects will be given a Patient Controller and instructed how to use the Patient Controller to adjust 
stimulation as needed to produce the best results  and to complete the Patient Trial Diary daily during the 
trial evaluation period   
 
BurstDR â„¢ Programming Guidelines can be found  in Appendix C.  
 
During the initial trial evaluation period, the stimulation parameters may be optimized. If this is needed, the 
subject would return to the clinic for adjustments to the programming parameters. Study personnel 
performing programming activ ities will utilize the same methods as the post -op programming to ensure the 
subject remains blinded to treatment group.  This visit should be documented as an unscheduled visit.  If a 
lead revision is needed during the trial period, the subject should be wi thdrawn from the study . 
 
All device programming session records will be emailed directly to Abbott from the Clinician Programmer 
by Abbott personnel or designee in xml format to the following email address:  CDOUpload@sjm.com . 
5.4.4 End of Initial Trial Evaluation Visit  
The initial trial evaluation period will be a minimum of 3 days . At the end of the initial trial evaluation period,  
the subject will be evaluated for qualification for permanent implant.  If the subje ct qualifies  for permanent 
implant, the subject will exit the study  and continue their treatment per the physicianâ€™s standard of care.  
 
If the subject does not qualify for permanent system implant after a minimum of 5 days, the subject may be 
re-programmed  with tonic stimulation, per physician discretion, and may enter  the extended trial evaluation 
period . The extended evaluation period must continue for an additional  minimum of  3 days .  
 
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 18 of 39 
                                             [REDACTED]   
 
Subjects will be re -programmed by trained personnel and/or an Abbott representative using the Clinician 
Programmer. Subjects will be instructed how to use the Patient Controller to adjust stimulation as needed 
to produce the best results  and to complete the Patient Trial Diary daily during the extended trial evaluation 
period 
For subjects continuing with the extended trial evaluation period record the required information on the 
applicable CRF:  
â€¢ NRS  
â€¢ Patient satisfaction and PRP  
â€¢ Stimulation assessment  
â€¢ Subjectâ€™s feedback  
â€¢ Lead location  
â€¢ Physician preference (if applicable - only a fter End of Initial Trial Period Visit for the last 
subject for a single site)  
â€¢ Adverse events (if applicable)  
â€¢ Deviations (if applicable)  
â€¢ Withdrawal (if applicable)  
â€¢ Death (if applicable)  
â€¢ Qualify for permanent implant  
 
Device programming session records wil l be emailed directly to Abbott from the Clinician Programmer by 
Abbott personnel or designee in xml format to the following email address:  CDOUpload@sjm.com . 
 
Upload and attach the following documentation to the a pplicable CRF:  
â€¢ Images  
 
The subject will continue to complete the Patient Trial Diary daily during the extended trial evaluation period 
(if applicable).  The subject will record areas of pain, stimulation therapy goals and percentage of pain relief.  
At the end of the extended trial evaluation period, the End of Trial Summary report will be submitted to the 
sponsor.  
Subjects who do not continue with the extended trial evaluation will exit the study  and continue their 
treatment per the physicianâ€™s standard of care.  
Record the required information on the applicable CRF:  
â€¢ NRS  
â€¢ Patient satisfaction and PRP  
â€¢ Stimulation assessment  
â€¢ Clinician assessment  
â€¢ Lead location  
â€¢ Adverse events (if applicable)  
â€¢ Deviations (if applicable)  
â€¢ Withdrawal (if applicable)  
â€¢ Death (if applicable)  
â€¢ Qualify for permanent implant  
 
Upload and attach the following documentation to the applicable CRF:  
â€¢ Images  
5.4.5 End of Extended Trial Evaluation Period (if applicable)  
Subjects will return to the clinic at the end of the extended trial evaluation period , at which time the subjectâ€™s 
participation in the clinical investigation is completed  regardless of qualification for permanent implant . 
Once the subject exits the study, t he subject will continue their treatment per the physicianâ€™s standard of 
care.  
 
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

5HFRUGWKHUHTXLUHGLQIRUPDWLRQRQWKHDSSOLFDEOH&5)
Â‡ 156Â‡ 3DWLHQWVDWLVIDFWLRQDQG353Â‡ 6WLPXODWLRQDVVHVVPHQWÂ‡ /HDG/RFDWLRQÂ‡ $GYHUVHHYHQWVLIDSSOLFDEOHÂ‡ 'HYLDWLRQVLIDSSOLFDEOHÂ‡ :LWKGUDZDOLIDSSOLFDEOHÂ‡ 'HDWKLIDSSOLFDEOHÂ‡ 4XDOLI\IRUSHUPDQHQWLPSODQW
8SORDGDQGDWWDFKWKHIROORZLQJGRFXPHQWDWLRQWRWKHDSSOLFDEOH &5)
Â‡ ,PDJHV
'HYLFHSURJUDPPLQJVHVVLRQUHFRUGV ZLOOEHHPDLOHGGLUHFWO\WR $EERWWIURPWKH&OLQLFLDQ3URJUDPPHUE\
$EERWWSHUVRQQHORUGHVLJQHHLQ[ POIRUPDWWRWKHIROORZLQJHPD LODGGUHVV&'28SORDG#VMPFRP

'XULQJWKHH[WHQGHGWULDOHYDOXDWL RQSHULRGWKHVWLPXODWLRQSD UDPHWHUVPD\EHRSWLPL]HG,IWKLVLVQHHGHG
WKHVXEMHFWZRXOGUHWXUQWRWKHF OLQLFIRUDGMXVWPHQWVWRWKHS URJUDPPLQJSDUDPHWHUV
 8QVFKHGXOHG9LVLWV
$QXQVFKHGXOHGYLVLWLVGHILQHG DVDQ\YLVLWZKHUHWKHVXEMHFW UHWXUQVWRWKHSDUWLFLSDWLQJVWXG\VLWHIRU
PHGLFDOFDUHRXWVLGHRIDVSHFLI LHGVWXG\YLVLW5HDVRQVIRUXQ VFKHGXOHGYLVLWVPD\LQFOXGHDQDGYHUVH
HYHQWZRXQGFKHFNRUSURJUDPPLQJ FKDQJHQRWSURWRFROVSHFLIL F
'XULQJWKHWULDOHYDOXDWLRQSHULRGVWKHVWLPXODWLRQSDUDPHWH UVPD\EHRSWLPL]HG,IWKLVLVQHHGHGWKH
VXEMHFWZRXOGUHWXUQWRWKHFOLQ LFIRUDGMXVWPHQWVWRWKHSURJU DPPLQJSDUDPHWHUV
5HFRUGWKHUHTXLUHGLQIRUPDWLRQRQWKHDSSOLFDEOH&5)
Â‡ 5HDVRQIRUYLVLWÂ‡ 3URJUDPPLQJWLPHLIDSSOLFDEOHÂ‡ /HDG/RFDWLRQLIDSSOLFDEOHÂ‡ $GYHUVHHYHQWVLIDSSOLFDEOHÂ‡ 'HYLDWLRQVLIDSSOLFDEOHÂ‡ :LWKGUDZDOLIDSSOLFDEOHÂ‡ 'HDWKLIDSSOLFDEOH

'HYLFHSURJUDPPLQJVHVVLRQUHFRUGVLIDSSOLFDEOHZLOOEHHPDL OHGGLUHFWO\WR$EERWWIURPWKH&OLQLFLDQ
3URJUDPPHU E\ $EERWW SHUVRQQHO RU GHVLJQHH LQ [PO IRUPDW WR WKH  IROORZLQJ HPDLO DGGUHVV
&'28SORDG#VMPFRP 
 3DWLHQW5HSRUWHG2XWFRPH352PHDVXUHV
7KH6WXG\&RRUGLQDWRURUGHVLJQHHZLOOJLYHWKHVXEMHFWTXHVWLR QQDLUHWRFRPSOHWHRQKLVRUKHURZQRU
DSSO\DQLQWHUYLHZWHFKQLTXH,WL VLPSRUWDQWWKHVXEMHFWXQGHU VWDQGVWKHPHDQLQJRIDOOZRUGVDQG
LQVWUXFWLRQVLQWKHTXHVWLRQQDLU HV7KHVXEMHFWVKRXOGEHLQVWU XFWHGWRDVNDQ\TXHVWLRQVDERXWWKH
TXHVWLRQQDLUHVLIIXUWKHUH[SODQDWLRQLV QHHGHG2QFHWKH TXHVW LRQQDLUHVDUHFRPSOHWHGWKH 6WXG\
&RRUGLQDWRURUGHVLJQHHZLOOUHYLHZIRUFRPSOHWHQHVVWRYHULI\ WKDWDOOTXHVWLRQVKDYHEHHQDQVZHUHGDQG
RQO\RQHUHVSRQVHLVFKRVHQI RUHDFKTXHVWLRQXQOHVVRWKHUZLVH QRWHG
7KHIROORZLQJ352PHDVXUHVZLOOEHFROOHFWHGDFFRUGLQJWRWKHV WXG\UHTXLUHPHQWV
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 1XPHULFDO5DWLQJ6FDOH156
7KHSDLQ156FRQVLVWVRITXHVWLRQWKDWZLOOEHDVNHGE\LQWHU YLHZLQJWKHVXEMHFWV7KHVXEMHFWVZLOOEH
DVNHGWRUDWHWKHLUDYHUDJHSDLQVSHFLILFWRWKHDUHDVRIFKU RQLFSDLQEHLQJWUHDWHGRYHUWKHSDVWKRXUV
RQDQRSDLQWRZRUVWLP DJLQDEOHSDLQVFDOH$KLJKHU VFRUHLQGLFDWHVDKLJKHUSDLQOHYHO7KH156
LVLPSOHPHQWHGLQWKH%DVHOLQH&5)WKH(QGRI,QLWLDO7ULDO(Y DOXDWLRQ3HULRG&5)RUWKH(QGRI([WHQGHG
7ULDO(YDOXDWLRQ3HULRG&5)
 3DWLHQW5HSRUWHG3DLQUHOLHI353
6XEMHFWVDUHDVNHGWRGLUHFWO\HVWLPDWHWKHSHUFHQWDJHRISDLQ UHOLHIH[SHULHQFHGGXULQJWKHWULDOSHULRGIURP
QRSDLQUHOLHIWRWRW DOSDLQUHOLHIHJÂ³,KDYH SDLQUHOLHIÂ´
 ,WHP$GXOW6FDOHRIWKH3DWLHQW5HSRUWHG2XWFRPHV0HDV XUHPHQW,QIRUPDWLRQ
6\VWHP3520,6'H\R5DPVD\%XFNOH\HWDO
7KH3520,6LVDQDGXOWVFDOHGHYHORSHGLQSDUWQHUVKLSZLWKW KH1DWLRQDO,QVWLWXWHVRI+HDOWK1,+WR
HVWLPDWHRYHUDOOTXDOLW\RIOLI HE\DVVHVVLQJWKHIROORZLQJGRP DLQVNQRZQWRLPSDFWDFWLYLWLHVRIGDLO\OLYLQJ
SK\VLFDOIXQFWLRQVOHHSGLVWXUEDQFHGHSUHVVLRQDQ[LHW\IDWL JXHSDLQLQWHUIHUHQFHSDLQLQWHQVLW\DQG
VRFLDOUROHVDWLVIDFWLRQ7KH VFDOHUHTXLUHVVXEMHFWVWRUDWH WKHIUHTXHQF\DQGRUVHYHULW\RIV\PSWRPVDQG
H[SHULHQFHVUHODWHGWRHDFKRIWK HVHGRPDLQVDQXPHULFDOUDWLQ JVFDOHIRUSDLQLQWHQVLW\ LVLQFOXGHG
RQWKHVFDOH$WRWDOVFRUHLVFDOFXODWHGDQGWUDQVIRUPHGDJDLQ VWQRUPDWLYHGDWDLQWRDWVFRUHLQGLFDWLQJ
JOREDOTXDOLW\RIOLIHLQUHODWLRQWRSRSXODWLRQQRUPV6XEVFD OHVDUHGHILQHGE\HDFKGRPDLQGHVFULEHG
DERYHDQGFDQEHH[DPLQHGVHSDUD WHO\WRSDUVHVHSDUDWHV\PSWRPV RUGHILFLHQFLHVLQTXDOLW\RIOLIH
$GGLWLRQDOO\DQLPSDFWVFRUHIRUFKURQLFORZEDFNSDLQZDVGHY HORSHGE\WKH1,+5HVHDUFK7DVN)RUFH
'H\R'ZRUNLQ$PWPDQQHWDOZKLFKLVFRPSXWHGXVLQJ WKHSDLQLQWHQVLW\SDLQLQWHUIHUHQFHDQG
SK\VLFDOIXQFWLRQVXEVFDOHV 'DWDFDSWXUHGLQWKLVVFDOHFDQE HXVHGLQDYDULHW\RIZD\VWRHVWDEOLVKSDWLHQW
FKDUDFWHULVWLFVDQGWUD FNFKDQJHVRYHUWLPH
 3DLQ&DWDVWURSKL]LQJ6FD OH3&66XOOLYDQ%LVKRS	3LY LN
7KH3&6LVDYDOLGDWHGVFDOHWKDWPHDVXUHVWKHPDJQLWXGHRIFDW DVWURSKL]LQJQHJDWLYHWKRXJKWVDQG
IHHOLQJVZKLOHDSDWLHQWLVH[S HULHQFLQJSDLQ 6XEMHFWVDQVZHU TXHVWLRQVDERXWKRZWKH\IHHODQGZKDWWKH\
WKLQNDERXWZKHQWKH\DUHLQSDLQLHQRWDWWKHFXUUHQWPRP HQW7KHVFDOHLQFOXGHVVWDWHPHQWV
FRQFHUQLQJSDLQH[SHULHQFHVWKDWDUHUDWHGRQDVFDOHEHWZHHQ ÂµQRWDWDOOÂ¶DQGÂµDOZD\VÂ¶7KHVFDOHLV
VHOIDGPLQLVWHUHGWDNHVPLQXWHVWRFRPSOHWHDQGH[DPLQHVWKH IROORZLQJWKUHHGRPDLQV5XPLQDWLRQ
0DJQLILFDWLRQDQG+HOSOHVVQHVV$KLJKHUVFRUHLQGLFDWHVDKLJK HUOHYHORIFDWDVWURSKL]LQJ7KH3&6LV
LPSOHPHQWHGLQWKH%DVHOLQH&5)
 6WLPXODWLRQ$VVHVVPHQW
7KH 6WLPXODWLRQ $VVHVVPHQW )RUP LQFOXGHV TXHVWLRQV WR LGHQWLI\ WKH VHQVDWLRQV H[SHULHQFHG ZKHQ
VWLPXODWLRQLVXVHG6XEMHFWVLGHQWLI\WKHLQWHQVLW\DQGDUHDV RIVHQVDWLRQVLIH[SHUL HQFHG,QWHQVLW\LVUDWHG
RQDVFDOHRIQRIHHOLQJWRYHU\LQWHQVH$PDSRIWKH ERG\LVODEHOHGZLWKGLIIHUHQWQXPEHUHG
TXDGUDQWVWRLGHQWLI\WKHDUHDVR IVHQVDWLRQV7KHVXEMHFWZLOO EHUHTXHVWHGYLDLQWHUYLHZWHFKQLTXHWR
LQGLFDWHWKHDUHDKHVKHLVIHHO LQJVHQVDWLRQV7KHIRUPZLOOE HLPSOHPHQWHGDW7ULDO6\VWHP,PSODQW,QLWLDO
7ULDO(YDOXDWLRQ9LVLW&5)(QG RI,QLWLDO7ULDO(YDOXDWLRQ9L VLW&5)DQG(QGRI([WHQGHG7ULDO9LVLW&5)
 &OLQLFLDQ$VVHVVPHQWV
7KHFOLQLFLDQDVVHVVPHQWRIWKHWZROHDGLPSODQWWHFKQLTXHVZL OOEHSHUIRUPHGDWWKHHQGRIHDFKWULDO
LPSODQWSURFHGXUHDQGDJDLQDWWKHHQGRIWKHVWXG\$WWKHHQGRIHDFKWULDOLPSODQWSURFHGXUHFOLQLFLDQVZLOOEH DVNHGWRUDWHWKHPDJ QLWXGHRIDQHVWKHVLD
UHODWHGGLIILFXOW\H[SHULHQFHGGXULQJWKHSURFHGXUHWKHPDJQLW XGHRIGLIILFXOW\LQSODFLQJWKHOHDGVDQG
WKHLUDIILQLW\OLNLQJIRUWKHWULDOLPSODQWSURFHGXUHSHUIRUP HGFRPSDUHGWRWKHLUXVXDOSUDFWLFH
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

$QHVWKHVLDUHODWHGGLIILFXOW\DQ G/HDG3ODFHPHQWGLIILFXOW\ZLO OEHDVVHVVHGZLWKDLWHP/LNHUWVFDOHV
1R'LIILFXOW\/LWWOH'LIILFXOW\ 0RGHUDWH'LIILFXOW\6HYHUH 'LIILFXOW\([WUHPH'LIILFXOW\Â±FRXOGQRWSODFH
OHDGV7RDVVHVVDIILQLW\OLNL QJFOLQLFLDQVZLOOEHDVNHG Â³2QDVFDOHIURPWRZLWKEHLQJÂµQRWDWDOOÂ¶
DQGEHLQJÂµYHU\PXFKÂ¶KRZPXFKGLG\RXOLNHWKLVWULDOLPSOD QWSURFHGXUHFRPSDUHGWR\RXUXVXDO
FOLQLFDOSUDFWLFHÂ´ 6FRUHVZLOOEHWUHDWHGDVPDJQLWXGHRIÂ³OL NLQJÂ´IRUHDFKSURFHGXUHDQGZLOOEHWDEXODWHG
DVLQWHUYDOGDWD$WWKHHQGRIWKHVWXG\FOLQLFLDQ Â¶VFRPSDUDWLYHSUHIHUHQFHIRU RQHSURFHGXUHRYHUWKHRWKHUZLOOEH
DVVHVVHGWKLVZLOOVHUYHDVWKHVHFRQGDU\HQGSRLQW&OLQLFLDQV ZLOOEHDVNHGWRFKRRVHHLWKHUÂ³$QDWRPLF
/HDG3ODFHPHQWÂ´RUÂ³7DUJHWHG/HDG 3ODFHPHQWÂ´LQUHVSRQVHWRWKH IROORZLQJTXHVWLRQÂ³&RQVLGHULQJ\RXU
VXEMHFWVÂ¶H[SHULHQFHVDQGRX WFRPHVDQG\RXUH[SHULHQFHVZLWKER WKOHDGSODFHPHQWWHFKQLTXHVZKLFK
WHFKQLTXHGR\RXSUHIHU"Â´
 'HVFULSWLRQRI$FWLYLWLHV3HUIRUPHGE\6SRQVRU5HSUHVHQWDWLYHV 
7UDLQHG6SRQVRUSHUVRQQHOZLOO SURYLGHWHFKQLFDOH[SHUWLVHDQG WHFKQLFDOJXLGDQFHRQWKHXVHRIWKH6&6
GHYLFHLQFOXGLQJWUDLQLQ JDQGSURFWRUHGFDVHFRYHUDJH
:KLOH6SRQVRUUHSUHVHQWDWLYHVPD\SHUIRUPWKHVHDFWLYLWLHVWKH 3ULQFLSDO,QYHVWLJDWRUUHPDLQVUHVSRQVLEOH
IRUHQVXULQJDOOFOLQLFDOLQYHVWL JDWLRQGDWDLVFROOHFWHGDVUH TXLUHGSHU&,3
 6XEMHFW6WXG\&RPSOHWLRQ
:KHQWKHVXEMHFWÂ¶VSDUWLFLSDWLRQLQWKHFOLQLFDOLQYHVWLJDWLRQ KDVEHHQFRPSOHWHGWKHVXEMHFWZLOOUHWXUQWR
WKHPHGLFDOFDUHDVSHUSK\VLFLDQÂ¶VUHFRPPHQGDWLRQ
 6XEMHFW:LWKGUDZDO
6XEMHFWVPXVWEHLQIRUPHGDERXW WKHLUULJKWWRZLWKGUDZIURPWK HFOLQLFDOLQYHVWLJDWLRQDWDQ\WLPHDQGIRU
DQ\UHDVRQZLWKRXWVDQFWLRQSHQDOW\RUORVVRIEHQHILWVWRZKL FKWKHVXEMHFWLVRWKHUZLVHHQWLWOHG
:LWKGUDZDOIURPWKHFOLQLFDOLQYHVWLJDWLRQZLOOQRWMHRSDUGL]H WKHLUIXWXUHPHGLFDOFDUHRUUHODWLRQVKLSZLWK
WKHLQYHVWLJDWRU6XEMHFWVZLOOEHUHTXHVWHGWRVSHFLI\WKHUHD VRQIRUWKHUHTXHVWWRZLWKGUDZ7KH
LQYHVWLJDWRUPXVWPDNHDOOUHDVRQDEOHHIIRUWVWRUHWDLQWKHVXE MHFWLQWKHFOLQLFDO LQYHVWLJDWLRQXQWLO
FRPSOHWLRQRIWKHFOLQLFDOLQYHVWLJDWLRQ([DPSOHVRIUHDVRQVIRUVXEMHFWÂ¶VZLWKGUDZDOLQFOXGHEXWDUHQ RWOLPLWHGWR

Â‡ 6XEMHFWDQGRUIDPLO\UHTXHVWWRZLWKGUDZFRQVHQW
Â‡ 6XEMHFWGHDWK
Â‡ 8QVXFFHVVIXOWULDOLPSODQWUHVXO WLQJLQLQHIIHFWLYHVWLPXODWL RQ
Â‡ /HDGUHYLVLRQÂ‡ 6\VWHPH[SODQW

7KHVWDWXVRIWKHVXEMHFWÂ¶VFRQGL WLRQVKRXOGEHGRFXPHQWHGDWW KHWLPHRIZLWKGUDZDO
 6WXG\&RPPLWWHHV
 6WHHULQJ&RPPLWWHH6&
$6WHHULQJ&RPPLWWHHZLOODGYLVH WKH6SRQVRURQNH\DVSHFWVUHO DWHGWRWKHGHYHORSPHQWH[HFXWLRQ
DQDO\VLVDQGUHSRUWLQJDQGRYHUD OOFRQGXFWRIWKHFOLQLFDOLQY HVWLJDWLRQ$6WHHULQJ&RPPLWWHHFKDUWHUZLOO
GHILQHPHPEHUVKLSRIWKHFRPPL WWHHDQGRXWOLQHWKHSXUSRVHURO HVUHVSRQVLELOLWLHVDQGJHQHUDOUXOHVRI
RSHUDWLRQIRUWKH6WHHULQJ&RPPLWWHH7KLVFKDUWHULVPDLQWDLQH GE\WKH6SRQVRUDQGVHWVIRUWKWKH
SURFHGXUHVIRUWKHLPSOHPHQWDWLRQR IWKH6WHHULQJ&RPPLWWHH
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 


$0HGLFDO0RQLWRUZLOOEHXWLOL]HGIRUWKLVVWXG\7KH0HGLFDO 0RQLWRULVUHVSRQVLEOHIRUUHYLHZLQJHDFK
VXEMHFWÂ¶VOHDGSODFHPHQWLPDJLQJWRGHWHUPLQHLIWKHOHDGSODFH PHQWJXLGHOLQHVZHUHIROORZHG2QFHWKH
LQYHVWLJDWRUFRPSOHWHVWKHWULDOLPSODQWSURFHGXUHWKHLPDJHV DQGDSSOLFDEOHVRXUFHGRFXPHQWDWLRQZLOOEH
SURYLGHGWRWKH0HGLFDO0RQLWRUIRUHYDOXDWLRQ,IWKH0HGLFDO 0RQLWRUGHWHUPLQHVWKDWWKHSDWLHQWZDV
LPSODQWHGRXWVLGHWKHUHTXLUHGJXLGHOLQHVDSURWRFROGHYLDWLRQ ZLOOEHLVVXHGDQGWKHSDWLHQWZLOOEH
H[FOXGHGIURPWK HSULPDU\HQGSRLQWDQDO\VLV
 6WDWLVWLFDO&RQVLGHUDWLRQV
7KHIROORZLQJVHFWLRQGHVFULEHVWKHVWDWLVWLFDOPHWKRGVIRUWKH FOLQLFDOLQYHVWLJDWLRQDQGMXVWLILFDWLRQRIWKH
GHVLJQ
 +\SRWKHVHV
 3ULPDU\(QGSRLQW+\SRWKHVLV
7KHSULPDU\HQGSRLQWLVLQWHQGHGWRGHPRQVWUDWHQRQLQIHULRULW\ RIWKHTXDOLILFDWLRQUDWHDWWKHHQGRIWKH
LQLWLDOWULDOHYDOXDWLRQSHULRG IRU*URXS$%FRPSDUHGWR*U RXS7%
)RUHDFKUDQGRPL]DWLRQJURXSWKH TXDOLILFDWLRQUDWHLVGHILQHG DVWKHQXPEHURIVXEMHFWVZKRDUHLGHQWLILHG
DVÂ³TXDOLILHGIRUSHUPDQHQWV\VW HPLPSODQWÂ´GLYLGHGE\WRWDOVX EMHFWVZKRFRPSOHWHWKHLQLWLDOWULDOHYDOXDWLRQ
SHULRGIRUWKHUHVSHFWLYHUDQGRPL]HGJURXS4XDOLILFDWLRQIRUSHUPDQHQWV\VWHPLPSODQWLVGHILQHGE\DFRPS RVLWHLQZKLFKDVXEMHFWPHHWVDOORIWKH
IROORZLQJFRQGLWLRQV
Â‡ !SDWLHQWUHSRUWHGSDLQUHOLHI353DWWKHHQGRIWKHWUL DOHYDOXDWLRQSHULRG
Â‡ 7ULDOHYDOXDWLRQSHULRGODVWHGIRUDPLQLPXPRIGD\V
Â‡ 3K\VLFLDQUHFRPPHQGVVXEMHFWIRUSHUPDQHQWV\VWHPLPSODQWÂ‡ 6XEMHFWUHSRUWVDZLOOLQJQHVV WRSXUVXHDSHUPDQHQWV\VWHPLP SODQW
Â‡ 
6XEMHFWVDUHQRWTXDOLILHGIRUSHUPDQHQWV\VWHPLPSODQWLIWKH\ PHHWERWKRIWKHIROORZLQJ
Â‡ Â”353DWWKHHQGRIWKHWULDOHYDOXDWLRQÂ‡ 7ULDOHYDOXDWLRQSHULRGODVWHGIRUDPLQLPXPRIGD\V
+\SRWKHVLV7KHK\SRWKHVLVLVIRUPDOO\DGGUHVVHGDV+
3$%37%Â”
+
3$%37%!

ZKHUH
3 $% SHUPDQHQWV\VWHPTXDOLILF DWLRQUDWHRI*URXS$%
3 7% SHUPDQHQWV\VWHPTXDOLILFDWLRQUDWHRI*URXS7%
7KHOLWHUDWXUHUHSRUWVUDWHVRIFRQYHUVLRQIURPWULDOWRSHUPDQ HQWLPSODQWXVLQJWRQLFVWLPXODWLRQUDQJLQJ
IURPWR
$QRQLQIHULRULW\PDUJLQRI LVVPDOOHUWKDQKDOIRIWKH ORZHVWUHSRUWHGUDWHRI
FRQYHUVLRQIURPWULDOWRSHUPDQHQ WLPSODQW$VVXPLQJDFRQYHUV LRQUDWHRIZKLFKLVPLGZD\WKURXJK
WKHUDQJHRIUDWHVUHSRUWHGD QRQLQIHULRULW\PDUJLQUHTXL UHVDQDWRPLFSODFHPHQWWREHDWOHDVW
ZKLFKLVDWWKHORZHUHQGRIWKHOLWHUDWXUHUHSRUWHGUDWHV
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 23 of 39 
                                             [REDACTED]   
 
6.1.1.1  Analysis Methodology  
 
The hypothesis will be tested at the 5% significance level. The analysis will be carried out by calculating 
the 95% lower confidence bound (LCB) on the difference of permanent system qualification rates between 
Group 1 and Group 2 (i.e. PAB â€“ PTB) using the Farrington -Manning  method . The null hypothesis will be 
rejected if the 95% LCB for PAB â€“ PTB is greater than -15%. 
 
6.1.1.2  Sample Size Determination  
 
In the SJM Prodigy I PMCF trial and EMPOWER study, the observed qualification rates for tonic stimulation 
were 82.6% (100/121) and 58.8% (77/131), respectively , and the po oled tonic qualification rate was 70% 
(=177/252) . Assuming th at BurstDR â„¢ stimulation qualification rate is similar to tonic stimulation, the sample 
size was calculated according to the assumption of qualification rates of 70% for BurstDR â„¢ stimulation  
using either anatomic lead placement (Group 1) or targeted lead placement  (Group 2). Under these 
assumptions, a sample size of 115 evaluable s ubjects for each arm would provide 80% power to reject the 
null hypothesis at 5% significance level. The sample size was estimated using PASS 13 (NCSS, LLC).  
 
6.1.1.3  Analysis Populations  
 
The analysis population includes subjects who are randomized and either qua lify for a permanent system 
implant or do not qualify for a permanent system implant, as defined earlier .   
6.1.1.4  Subgroup Analysis  
 
The primary endpoint will be reported separately for female and male subjects .  
6.1.1.5   Missing Data  
 
A sensitivity analysis will be carried in the same manner as the primary analysis, except the subjects who 
were randomized, underwent the trial system implant and did not complete the initial trial period will be 
included in the analysis and be treated as non -qualified subjects.  
6.1.2 Seconda ry Endpoint Hypothesis  
The secondary endpoint is intended to demonstrate physici an prefer ence for  anatomic placement over 
targeted placement.  
 
Hypothesis : 
The hypothesis is formally addressed as:  
 
H0: P â‰¤ 60%  
 
H1: P > 60%   
 
where P= percentage of physician prefer anatomic placement over targeted placement.  
 
Analysis  
The hypothesis will be tested at the 5% significance level. The analysis population includes physician s who 
have performed both placement procedures. The analysis will be carried out b y calculating the 95% LCB 
on the percentage of physicians who prefer anatomic placement over targeted placement (P) using the 
Clopper -Pearson exact method. The null hypothesis will be rejected if the 95% LCB for P is greater than 
60% (e.g., if the proporti on of subjects is greater than that expected by chance , i.e., 50%) .  
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 -XVWLILFDWLRQRI&OLQLFDO,QYHVWLJDWLRQ'HVLJQ
7RGDWHQRFOLQLFDOHYLGHQFHK DVEHHQJHQHUDWHGIRUWKHXVHRI %XUVW'5GXULQJWULDOHYDOXDWLRQIRU6&6RU
IRUWKH,QYLVLEOH7ULDO6\VWHPZLWKDQ\VWLPXODWLRQPRGH%XUVW '5XVHGZLWKSHUPDQHQW6&6V\VWHPVKDV
SURYLGHGEHWWHUSDWLHQWH[SHULHQFHVFRPSDUHGWRWRQLFVWLPXODWL RQHJSDLQUHOLHIDQGVDWLVIDFWLRQ7KH
WULDOV\VWHPFDSDEOHRIGHOLYHULQJERWK%XUVW'5DQGWRQLFVWLP XODWLRQPRGHVPD\SURYLGHDGGLWLRQDO
EHQHILWVE\PDNLQJ%XUVW'5DYDLOD EOHGXULQJWKHWULDOHYDOXDWLR QDQGE\SURYLGLQJDQDOWHUQDWLYHVWLPXODWLRQ
PRGHLI%XUVW'5IDLOV)XUWKHUPRUHWKH,QYLVLEOH7ULDO6\VWHP SURYLGHVDVWUHDPOLQHGZLUHIUHHWULDO
H[SHULHQFHIRUVXEMHFWVDQGHVWD EOLVKLQJVXEMHFWLPSUHVVLRQVR IWKHV\VWHPDUHLQWHJUDOWRWKHPDUNHWLQJ
RIWKLVLPSURYHGV\VWHP7KHSULPDU\DLPRIWKLVFOLQLFDO LQYHVWLJDWLRQLVWRHVWDEOLVK WKDWDQDWRPLFOHDGSODFHPHQWIRU%XUVW'5WULDOV
UHVXOWVLQQRQLQIHULRUTXDOLILFDWLRQUDWHVFRPSDUHGWRWKHWUD GLWLRQDOWDUJHWHGOHDGSODFHPHQWWHFKQLTXH7KH
DELOLW\WRDQDWRPLFDOO\SODFHWU LDOOHDGVLVSRWHQWLDOO\LPSRUW DQWEHFDXVHLWVKRXOGUHGXFHSURFHGXUHWLPH
ZKLFKEHQHILWVERWKSK\VLFLDQVDQ GSDWLHQWV3ULRUWRWKHDYDLO DELOLW\RI%XUVW'5VWLPXODWLRQDQDWRPLF
SODFHPHQWZDVQRWLQGLFDWHGGX HWRWKHVHQVRU\H[SHULHQFHVRIW RQLFVWLPXODWLRQ7KXVWKHFXUUHQWFOLQLFDO
LQYHVWLJDWLRQZLOOHVWDEOLVKWKHIHDVLELOLW\RIWKHDQDWRPLFSO DFHPHQWSURFHGXUH$GGLWLRQDOO\HVWDEOLVKLQJ
WKHSK\VLFLDQÂ¶VSUHIHUHQFHRIDQDWRPL FSODFHPHQWDQGWKHHIIHFW RIDQDWRPLFSODFHPHQWRQSURFHGXUHWLPH
ZLOOLQIRUPFOLQLFDOFDUH7KXVWKHFKRVHQHQGSRLQWVFDSWXUH TXDOLILFDWLRQUDWHSK\VLFLDQSUHIHUHQFH
SURFHGXUHWLPHDQGGHVFULSWLYHLQIRUPDWLRQ$OORIWKHVHDUHG HVLJQHGWRH[SORUHSURFHG XUHEHQHILWVFOLQLFDO
H[SHULHQFHDQGSD WLHQWH[SHULHQFH
7ROLPLWNQRZOHGJHELDVWKLVF OLQLFDOLQYHVWLJDWLRQZLOOEHVL QJOHEOLQGHGLHVXEMHFWVZLOOQRWEHPDGHDZDUH
RIWKHJURXSWRZKLFKWKH\DUHUDQGRPL]HG$GGLWLRQDOO\DVW DQGDUGL]HGVFULSWZLOOEHSURYLGHGWRVWXG\
VLWHSHUVRQQHOWRDVVLVWZLWKSDWLHQWLQWHUDFWLRQDVDZD\WRP LQLPL]HWKHULVNRIGLVFORVLQJUDQGRPL]DWLRQ
DVVLJQPHQWV
7KHSULPDU\PDUNHURIVXFFHVVGXULQ JWKHW\SLFDO6&6WULDOHYDO XDWLRQSHULRGLVTXDOLILFDWLRQIRUSHUPDQHQW
LPSODQW4XDOLILFDWLRQSHUVWDQGDUGRIFDUHIRU6&6GHYLFHVLQF OXGHVDVXFFHVVIXOWULDOHYDOXDWLRQSHULRG
GHILQHGE\VXEMHFWÂ¶VDVVHVVPHQWRIRUPRUHSDLQUHOLHIGXUL QJWKHWULDOHYDOXDWLRQSK\VLFLDQÂ¶V
UHFRPPHQGDWLRQDQGWKHVXEMHFWÂ¶ VZLOOLQJQHVVWRFRQWLQXHWRWK HSHUPDQHQWV\VWHP$VVXFKWKHFXUUHQW
FOLQLFDOLQYHVWLJDWLRQ GHILQHVTXDOLILFDWLRQIRUSHUPDQHQWLPSO DQWDVDFRPSRVLWHHQGSRLQWEDVHGXSRQ
VWDQGDUGRIFDUHWREHXVHGDVI RUWKHSULPDU\HQGSRLQW'HPRQV WUDWLRQRIQRQLQIHULRULW\ZLOOHVWDEOLVKWKDW
WKHDQDWRPLFSODFHPHQWWHFKQLTXH LVVLPLODUWRWUDGLWLRQDOWDU JHWHGWHFKQLTXHVLQWHUPVRIVXEMHFWVHOHFWLRQ
IRUSHUPDQHQWLPSODQW6HFRQGDU\ DQGGHVFULSWLYHHQGSRLQWVZLOO SURYLGHHYLGHQFHRIWKHSK\VLFLDQDQG
SDWLHQWH[SHULHQFHZLWKERWKW \SHVRILPSODQWSURFHGXUHVDQGZL WKWKH,QYLVLEOH7ULDO6\VWHPRYHUDOO
$VWKHSULPDU\K\SRWKHVLVZLOO EHWHVWHGSULRUWRDFWXDOSHUPDQ HQWLPSODQWVWDWXVWKHFOLQLFDOLQYHVWLJDWLRQ
ZLOOHQGDWWKHTXDOLILFDWLRQVWDJHZLWKRXWFRQVLGHUDWLRQRIWK HDFWXDOSHUPDQHQWLPSOD QWVWDWXVIRUVXEMHFWV
4XDOLILFDWLRQEDVHGRQHIILFDF\ VXEMHFWVHOIVHOHFWLRQDQGSK \VLFLDQGLVFUHWLRQLVVXIILFLHQWWRPDNH
LQIHUHQFHVDERXWWKHDQDWRPLFSURFHGXUHDQG,QYLVLEOH7ULDO6\V WHPIHDWXUHV

)DLOXUHWRTXDOLI\IRUWKLVVWXG\LVFRQWLQJHQWXSRQDPLQLPXP RIGD\VRIVWLPXODWLRQ$QHFGRWDOUHSRUWV
LQGLFDWHGWKDWEXUVWVWLPXODWLRQPD\WDNHXSWRGD\VWRLPSDU WIXOOEHQHILWZKHUHDVWRQLFVWLPXODWLRQGRHV
QRWKLVWRULFDOO\KDYHDZDVKLQSHULRGWRUHDFKIXOOEHQHILW $VVXFKIDLOXUHVRFFXUULQJEHIRUHGD\VPD\
EHDSURGXFWRILQVXIILFLHQWH[SR VXUHWREXUVWWKHUDS\DQGWKH SULPDU\HQGSRLQWLVFRQWLQJHQWXSRQHTXLWDEOH
WUHDWPHQWEHWZHHQUDQGRPL]DWLRQDUPVLQDOORWKHUDVSHFWVH[FHS WLQJSURFHGXUH$GGLWLRQDOO\VXEMHFWVZKR
IDLOWKHEXUVWWULDODQGSURFHHGWR DQH[WHQGHGWULDOHYDOXDWLR QZLWKWRQLFVWLPXODWLRQZLOOQHHGWRHQVXUHWKDW
WKH\DUHSURYLGHGVXIILFLHQWWLPHWRDVVHVVWKHDOWHUQDWHVWLPX ODWLRQPRGH$WSUHVHQWWKHZDVKRXWSHULRG
IRUEXUVWLIDQ\KDVQRWEHHQHVWDEOLVKHGEXWLVVXVSHFWHGWR EHDWOHDVWDIHZKRXUVDQGXSWRGD\V$V
VXFKVXEMHFWÂ¶VHQGLQJWKHLUWULDOHYDOXDWLRQEHIRUHGD\VZLW
KRXWPHHWLQJFULWHULDIRUTXDOLILFDWLRQIRU
SHUPDQHQWLPSODQWZLOOEHFRQVL GHUHGDGHYLDWLRQDQGWUHDWHGDV PLVVLQJGDWD8VHRIWKL VFULWHULRQZLOODOVR
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

DOORZH[SORUDWRU\DQDO\VHVIRUSR WHQWLDOZDVKLQDQGZDVKRXWS HULRGVIRUEXUVWVWLPXODWLRQWKDWDUH\HWWR
EHHVWDEOLVKHGLQDFOLQLFDOVWXG\
 0XOWLSOLFLW\
7KHUHLVRQHSULPDU\HQGSRLQWDQGRQHVHFRQGDU\HQGSRLQWRIWKL VFOLQLFDOLQYHVWLJDWLRQ7KHVHFRQGDU\
HQGSRLQWZLOOEHWHVWHGZKHQWKH SULPDU\HQGSRLQWLVPHW7KHUH IRUHQRPXOWLSOLFLW\DG MXVWPHQWLVQHHGHG
 2YHUDOO6DPSOH6L]H
$VVXPLQJDWWULWLRQUDWHZKL FKDFFRXQWVIRUGURSRXWIURPFR QVHQWWRUDQGRPL]DWLRQDQGIURP
UDQGRPL]DWLRQWRFRQWULEXWLQJWRWKHDQDO\VLVSRSXODWLRQDVDP SOHVL]HRI 
VXEMHFWVZLOO
EHHQUROOHGDWXSWRVLWHVLQWKH(0($$1=&$DQG86UHJLRQV 
 'HVFULSWLYH(QGSRLQWV
'HVFULSWLYHHQGSRLQWVDUHUHSRUWHGXVLQJRQO\VXPPDU\VWDWLVWLF VDQGQRK\SRWKHVLVWHVWVZLOOEHSHUIRUPHG

 2YHUDOOSURFHGXUHWLPHLQURRPWRRXWURRPLPSODQWSURFHG XUHWLPHQHHGOHLQWRQHHGOHRXW
DQGWRWDOWLPHRILQWUDRSHUDWLYHIOXRURVFRS\H[SRVXUHIRUHDFK UDQGRPL]HGJURXSDQGVWUDWLILHGE\
QXPEHURIOHDGVDQGOHDGW\SHS HUPDQHQWOHDGRUWHPSRUDU\OHDG 
 3URJUDPPLQJWLPHUHTXLUHGIRUHDFKUDQGRPL]HGJURXS &KDQJHIURPSUHLPSODQW1XPHULFDO5DWLQJ6FDOH156LQHDFK UDQGRPL]HGJURXSWRHQGRILQLWLDO
WULDOHYDOXDWLRQSHULRGDQGWRW KHHQGRIWKHH[WHQGHGWULDOHY DOXDWLRQSHULRGDVDSSOLFDEOH
 1XPEHURIVXEMHFWVLQHDFKUDQGRPL]HGJURXSZKRKDYHDIILUPD WLYHDVVHVVPHQWIRUHDFKRIWKH
LQGHSHQGHQWFULWHULDUHTXLUH GIRUTXDOLILFDWLRQIRUSHUPDQHQWL PSODQW
 3URSRUWLRQRIVXEMHFWVLQHDFKUDQGRPL]HGJURXSZKRGRQRWT XDOLI\IRUSHUPDQHQWLPSODQW
KRZHYHUGRSURFHHGZLWKSHUPDQHQWLPSODQWSHUSK\VLFLDQGLVFUHW LRQ
 7LPHIURPWULDOV\VWHPLPSODQWWR!353PHDVXUHGE\WKHQ XPEHURIGD\VDOVRNQRZQDV
Â³ZDVKLQSHULRGÂ´
 5DWHRIVHULRXVDGYHUVHGHYLFHHIIHFWV6$'(LQHDFKJURXS 
 1XPEHUDQGSURSRUWLRQRIPHDQL QJIXOOHDGPLJUDWLRQV
GXULQJ WKHLQLWLDOWULDOHYDOXDWLRQSHULRGVE\
WUHDWPHQWJURXS
 1XPEHUDQGSURSRUWLRQRIPHDQL QJIXOOHDGPLJUDWLRQV
GXULQJ WKHLQLWLDOWULDOHYDOXDWLRQSHULRGLQ
VXEMHFWVZKRKDYHDWHPSRUDU\WULDOOHDGLPSODQWFRPSDUHGWRVX EMHFWVZKRKDYHDSHUPDQHQWWULDO
OHDGLPSODQW
&OLQLFLDQDVVHVVPHQWRIDQ HVWKHVLDUHODWHGGLIILFXOW\DVVH VVHGSULPDULO\LQWKH SURFHGXUHURRPIRU
WKHWULDORQDSRLQWOLNHUWVFDOHIRUHDFKUDQGRPL]HGJURXS 
&OLQLFLDQDVVHVVPHQWRIOHDG SODFHPHQWGLIILFXOW\RQDSR LQWOLNHUWVFDOHIRUHDFKUDQGRPL]HG
JURXS
&OLQLFLDQDIILQLW\OLNLQJIRUOHDGSODFHPHQWWHFKQLTXHDW WKHHQGRIWKHWULDOLPSODQWSURFHGXUH
3HUPDQHQWV\VWHPTXDOLILFDWLRQUDWHDWWKHHQGRIH[WHQGHG WULDOSHULRG


$PHDQLQJIXOOHDGPLJUDWLRQLVGHILQHGDVDOHDGPLJUDWLRQUHV XOWLQJLQWKHLQDELOLW\WRSURJUDPIRUWKHUDSHXWLF
UHVSRQVH
 7LPLQJRI$QDO\VLV
$QDO\VLVZLOOEHSHUIRUPHGZKHQWKHODVWHQUROOHGVXEMHFWFRPSO HWHVWKHLQLWLDOWULDOHYDOXDWLRQRULIVXEMHFW
IDLOHGWRTXDOLI\GXULQJWKHLQLWLDOWULDOHYDOXDWLRQSHULRGDQ GSDUWLFLSDWHGLQWKHH[WHQGHGWULDOSHULRGDIWHU
FRPSOHWLRQRIWKHH[W HQGHGWULDOSHULRG
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 6XFFHVV&ULWHULD
7KHFOLQLFDOLQYHVWLJDWLRQZLOO EHFRQVLGHUHGDV XFFHVVZKHQWK HSULPDU\HQGSRLQWLVPHW
 ,QWHULP$QDO\VLV
1RLQWHULPDQDO\VHVDUHSODQQHGIRUWKLVVWXG\
 6WDWLVWLFDO&ULWHULDIRU7HUPLQDWLRQ
7KHUHDUHQRVWDWLVWLFDOFULW HULDIRUWHUPLQDWLRQRIWKLVFOLQL FDOLQYHVWLJDWLRQ 
 'HYLDWLRQVIURP6WDWLVWLFDO3ODQ
,IDQ\GHYLDWLRQVIURPWKHRULJL QDOVWDWLVWLFDOSODQRFFXUVXF KGHYLDWLRQVZLOOEHGRFXPHQWHGLQWKHFOLQLFDO
VWXG\UHSRUWRUVWDWLVWLFDOUHSR UWFRQWDLQLQJWKHDQDO\VLVUHVX OWV
 5LVNVDQG%HQHILWV
7KHULVNVDVVRFLDWHGZLWKWKHXVHRIWKHÂµ,QYLVLEOH7ULDO6\VWH PÂ¶DUHDQWLFLSDWHGWREHFRPSDUDEOHWRWKRVH
DVVRFLDWHGZLWKWKHXVHRIRWKHUFXUUHQWO\DYDLODEOH6&6WULDO V\VWHPV6XEMHFWVSDUWLFLSDWLQJLQWKLVVWXG\
DUHLQGLFDWHGIRUDQ6&6WULDOQHXURPRGXODWLRQV\VWHPDVSDUWR IWKHLUVWDQGDUGPHGLFDOPDQDJHPHQWDQG
DUHVXEMHFWWRWKHULVNDVVRFLDWH GZLWKWKHXVHRIWKHVHGHYLFH V7KHVWXG\GRHVQRWUHTXLUHDQ\DGGLWLRQDO
SURFHGXUHVRUDVVHVVPHQWVRYHUWKHVWDQGDUGRIFDUH7KLVVWXG\PD\RUPD\QRWEHQHILWWKHVXEMHFWVLQYROYHGEXWPD \KHOSIXWXUHVXEMHFWVE\LQFUHDVLQJFXUUHQW
NQRZOHGJH DQG XQGHUVWDQGLQJ RI WUHDWPHQW RSWLRQV IRU VXEMHFWV Z KR DUH LQGLFDWHG IRU WKH WULDO
QHXURPRGXODWLRQV\VWHPIRU6&6/HDGSODFHPHQWIRU%XUVW'5ÂŒKDVSURFHHGHGWRXVHWHPSRUDU\WRQL FVWLPXODWLRQVXFKWKDWWKHVHQVRU\
TXDOLWLHVRIWRQLFSURJUDPPLQJSDUHVWKHVLDVFDQEHXVHGWRHO LFLWIHHGEDFNIURPSDWLHQWVDQGHQVXUHWKH
OHDGVDUHSURSHUO\SODFHGDQGSURJUDPPHG%HFDXVH%XUVW'5ÂŒUHVX OWVLQVHQVDWLRQIUHHWKHUDS\IRUPRVW
SDWLHQWVLWKDVEHHQSURSRVHG WKDWDQDWRPLFSODFHPHQWRIWKHO HDGVFRXOGUHVXOWLQHIIHFWLYHWKHUDS\ZKLOH
UHGXFLQJSURFHGXUHWLPHVGXULQJERWKWKHWULDOHYDOXDWLRQDQGS HUPDQHQWV\VWHPLPSODQWV7KLVEHQHILWPD\
EHDSSOLFDEOHIRUVXEMHFWVUDQGRPL]HGWR*URXS$%
 5LVNV$VVRFLDWHGZLWKWKH'HYLFH8QGHU,QYHVWLJDWLRQ
7KHUHDUHQRDGGLWLRQDOULVNVWRWKHVWXG\VXEMHFWVEH\RQGWKRV HDVVRFLDWHGZLWKWKHLPSODQWDQGXVHRIWKH
DSSURYHGWULDOQHXURPRGXODWLRQV\VWHPV3OHDVHUHIHUWRVHFWLRQ IRUWKHOLVWRIDQWLFLSDWHGDGYHUVH
HYHQWV
 $QWLFLSDWHG$GYHUVH'HYLFH(IIHFWV
7KHLPSODQWDWLRQRID6&6WULDOV\VWHPLVDQLQYDVLYHSURFHGXUH DQGWKHUHIRUHFDUULHVFHUWDLQULVNV,Q
DGGLWLRQWRWKRVHULVNVFRPPRQO\ DVVRFLDWHGZLWKVXUJHU\WKHI ROORZLQJDQWLFLSDWHGD GYHUVHGHYLFHHIIHFWV
DUHDVVRFLDWHGZLWKLPSODQWLQJRUXVLQJWKHWULDOQHXURPRGXODWL RQV\VWHPIRU6&6

x 8QSOHDVDQWVHQVDWLRQVRUPRWRU GLVWXUEDQFHVLQF OXGLQJLQYROXQ WDU\PRYHPHQWFDXVHGE\
VWLPXODWLRQDWKLJKRXWSXWV,IHLWKHURFFXUVWXUQRIIWKH(3* LPPHGLDWHO\
x 8QGHVLUDEOHFKDQJHVLQVWLPXO DWLRQZKLFKPD\EHUHODWHGWRFH OOXODUFKDQJHVLQWLVVXHDURXQGWKH
HOHFWURGHVFKDQJHVLQHOHFWURGHS RVLWLRQORRVHHOHFWULFDOFRQ QHFWLRQVRUOHDGIDLOXUH
x 6WLPXODWLRQLQXQZDQWHGSODFHV
x /HDGPLJUDWLRQFDXVLQJFKDQJHV LQVWLPXODWLRQRUUHGXFHGSDLQ UHOLHI
x (SLGXUDOKHPRUUKDJH
x +HPDWRPD
x ,QIHFWLRQ
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

x 6SLQDOFRUGFRPSUHVVLRQ
x 3DUDO\VLVIURPSODFHPHQWRIDOHDGLQWKHHSLGXUDOVSDFH
x &HUHEURVSLQDOIOXLG&6)OHDNDJH
x 3DUDO\VLV
x :HDNQHVVFOXPVLQHVVQXPEQHVV RUSDLQEHORZWKHOHYHORIWKH LPSODQW
x $OOHUJLFRUUHMHFWLRQUHVSRQ VHWRLPSODQWPDWHULDOV
x 6HURPDPDVVRUVZHOOLQJDWWKHLPSODQWVLWH
x /RFDOVNLQHURVLRQ
x 3HUVLVWHQWSDLQDWOHDGVLWH
 5LVNV$VVRFLDWHGZLWK&OLQLFDO,QYHVWLJDWLRQ$VVHVVPHQWV
7KHULVNVLQYROYHGZLWKWKLVFOLQ LFDOLQYHVWLJDWLRQDUHFRPSDUD EOHWRWKRVHDVVRFLDWHGZLWKWKHLPSODQWRIDQ\
RWKHUFRPPHUFLDOO\DYDLODEOHQHXURPRGXODWLRQV\VWHP
 5LVN&RQWURO0HDVXUHV
(YHU\SRVVLEOHHIIRUWZLOOEHWDNH QWRPLQLPL]HWKHULVNVLQFO XGLQJ
x &DUHIXOVHOHFWLRQRIH[SHULHQFHG,QYHVWLJDWRUVIRUWKHFOLQLFD OLQYHVWLJDWLRQ
x $GHTXDWHPRQLWRULQJIRUHDFKFOLQLFDOLQYHVWLJDWLRQVLWH
x &RQGXFWLQJWKHFOLQLFDOLQYHVWLJDWLRQLQDFFRUGDQFHZLWKWKH& ,3DOODSSOLFDEOHODZVDQG
UHJXODWLRQVDQGDQ\FRQGLWLRQV RIDSSURYDOLPSRVHGE\WKHDSSUR SULDWH,5%(&RUDSSOLFDEOH
UHJXODWRU\DXWKRULWLHVZKHUHWKH FOLQLFDOLQYHVWLJDWLRQLVSHUI RUPHG
x 7UDLQLQJRI,QYHVWLJDWRUVERWKRQWKH&,3OHDGSODFHPHQWSURF HGXUHDQFKRULQJWHFKQLTXHDQG
LPDJLQJJXLGHOLQHV
 3RVVLEOHLQWHUDFWLRQVZLWKFRQFRPLWDQWWUHDWPHQWV
7KHUHDUHQRNQRZQLQWHUDFWLRQVRIWKHQHXURPRGXODWLRQWULDOV\ VWHPZLWKFRQFRPLWDQ WPHGLFDOWUHDWPHQW
RUZLWKDQ\SUHYLRXVO\LPSODQWHGDFWLYHGHYLFHV3OHDVHUHIHUW RWKH&OLQLFLDQÂ¶V0DQXDOIRUWKH6-070
([WHUQDO3XOVH*HQHUDWRUDQGOHDGVIRULQIRUPDWLRQUHODWHGWR0 5,FRPSDWLELOLW\
 5LVNWR%HQHILW5DWLRQDOH
$Q\XQGHVLUDEOHVLGHHIIHFWVXQ GHUQRUPDOFRQGLWLRQVRIXVHD UHFRQVLGHUHGWREHDFFHSWDEOHULVNVZKHQ
ZHLJKHGDJDLQVWWKHSHUIRUPDQFHR IWKHGHYLFHDQGEHQHILWVWRW KHVXEMHFW
 5HTXLUHPHQWVIRU,QYHVWLJDWRU5HFRUGVDQG5HSRUWV
 'HYLDWLRQVIURP&,3
$GHYLDWLRQLVGHILQHGDVDQLQVWDQFHVRIIDLOXUHWRIROORZ LQWHQWLRQDOO\RUXQLQWHQWLRQDOO\WKHUHTXLUHPHQWV
RIWKH&,37KHLQYHVWLJDWRUVK RXOGQRWGHYLDWHIURPWKH&,3

,QVRPHFDVHVIDLOXUHWRFRPSO\ZLWKWKH&,3PD\EHFRQVLGHUHG IDLOXUHWRSURWHFWWKHULJKWVVDIHW\DQG
ZHOOEHLQJRIVXEMHFWVVXFKQRQFRPSOLDQFHH[SRVHVVXEMHFWVWR XQUHDVRQDEOHULVNV([DPSOHVIDLOXUHWR
DGKHUHWRWKHLQFOXVLRQH[FOXVLRQFULWHULDIDLOXUHWRSHUIRUP VDIHW\DVVHVVPHQWVLQWHQGHGWRGHWHFWDGYHUVH
HYHQWV,QYHVWLJDWRUVV KRXOGVHHNWRPLQLPL]HVXFKULVNVE\DGK HULQJWRWKH&,3
7KH3,PXVWPDLQWDLQDFFXUDWHFRPSOHWHDQGFXUUHQWUHFRUGVL QFOXGLQJGRFXPHQWVVKRZLQJWKHGDWHRI
DQGUHDVRQIRUHDFKGHYLDWLRQI URPWKH&,35HOHYDQWLQIRUPDWLR QIRUHDFKGHYLDWLRQZLOOEHGRFXPHQWHGDV
VRRQDVSRVVLEOHRQWKHDSSOL FDEOH&5)7KHVLWHZLOOVXEPLWWK H&5)WRWKH6SRQVRU

7KH3,LVUHTXLUHGWRDGKHUHWRORFDOUHJXODWRU\UHTXLUHPHQWVI RUUHSRUWLQJGHYLDWLRQVWR,5%(&
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 


8QGHUHPHUJHQF\FLUFXPVWDQFHVGHY LDWLRQVIURPWKH&,3WRSURWH FWWKHULJKWVVDIHW\DQGZHOOEHLQJRI
VXEMHFWVPD\SURFHHGZLWKRXWSULRUDSSURYDORIWKH6SRQVRUDQG WKH,5%(&6XFKGHYLDWLRQVVKDOOEH
GRFXPHQWHGDQGUHSRUWHGWRWKH 6SRQVRUDQGWKH,5%(&DVVRRQD VSRVVLEOH
 6DIHW\5HSRUWLQJ
6DIHW\VXUYHLOODQFHDQGVDIHW\UHSRUWLQJE\WKHLQYHVWLJDWRUVW DUWVDVVRRQDVWKHVXEMHFWLVHQUROOHGLQWKLV
FOLQLFDOLQYHVWLJDWLRQ GDWHRIVLJQDWXUHR ILQIRUPHGFRQVHQW 
7KHVDIHW\VXUYHLOODQFHDQGWKHVDIHW\UHSRUWLQJZLOOFRQWLQXH XQWLOWKHODVWLQYHVWLJDWLRQDOYLVLWKDVEHHQ
SHUIRUPHGWKHVXEMHFWLVGHFHDV HGWKHVXEMHFWLQYHVWLJDWRUFR QFOXGHVKLVSDUWLFLSDWLRQLQWRWKHFOLQLFDO
LQYHVWLJDWLRQRUWKHVXEMHFWZLWKGUDZDOIURPWKHFOLQLFDOLQYHV WLJDWLRQ
3HUWKLV&,3WKHDSSOLFDEOHUHSRUWDEOHDGYHUVHHYHQWVGDWDLQF OXGLQJGHDWKVZLOOEHFROOHFWHGWKURXJKRXW
WKHFOLQLFDOLQYHVWLJDWLRQDQGZLOOEHUHSRUWHGWRWKH6SRQVRU WKURXJKWKH('&V\VWHP7KH6SRQVRUZLOO
HQVXUH WKDW DOO DSSOLFDEOH HYHQWV DUH UHSRUWHG WR WKH UHOHYDQW DXWKRULWLHV DV SHU UHJXODWLRQV 7KH
LQYHVWLJDWRUVPXVWQRWLI\WKH,5%(&LIDSSURSULDWHLQDFFRUG DQFHZLWKWKHLULQVWLWXWLRQDOUHTXLUHPHQWV
QDWLRQDODQGORFDOODZVDQGUH JXODWLRQVRIWKH$(VUHSRUWHGWR WKH6SRQVRU
$GYHUVHHYHQWVZLOOEHPRQLWRUHGXQWLOWKH\DUHDGHTXDWHO\UHVR OYHGRUWKHVXEMHFWKDVHQGHGKLVKHU
SDUWLFLSDWLRQLQWKHFOLQLFDOLQYHVWLJDWLRQZKLFKHYHUFRPHVIL UVW7KHVWDWXVRIWKHVXEMHFWÂ¶VFRQGLWLRQVKRXOG
EHGRFXPHQWHGDWHDFKYLVLW'HVFULSWLYHHQGSRLQWVIRUWKHVDIHW\GDWDSRLQWVDUHDVIROORZV 
 5DWHRIVHULRXVDGYHUVHGHYLFHHIIHFWV6$'(LQHDFKJURXS 
 1XPEHUDQGSURSRUWLRQRIPHDQL QJIXOOHDGPLJUDWLRQV
GXULQJ WKHLQLWLDOWULDOHYDOXDWLRQSHULRGVE\
WUHDWPHQWJURXS
 1XPEHUDQGSURSRUWLRQRIPHDQLQJIXOOHDGPLJUDWLRQV
GXULQJ WKHLQLWLDOWULDOHYDOXDWLRQSHULRGVLQ
VXEMHFWVZKRKDYHDWHPSRUDU\WULDOOHDGLPSODQWFRPSDUHGWRVX EMHFWVZKRKDYHDSHUPDQHQWWULDO
OHDGLPSODQW

$PHDQLQJIXOOHDGPLJUDWLRQLV GHILQHGDVDOHDGPLJUDWLRQUHV XOWLQJLQWKHLQDELOLW\WRSURJUDPIRU
WKHUDSHXWLFUHVSRQVH)RUWKHSXUSRVHVRIWKLVFOLQLFDO LQYHVWLJDWLRQWKHIROORZLQJ HYHQWVZLOOEHUHSRUWHG

x $OO$GYHUVH'HYLFH(IIHFWVQRQVHULRXVGHYLFHSURFHGXUHUHODW HG
x $OO6HULRXV$GYHUVH(YHQWVZK HWKHURUQRWWKHHYHQWLVFRQVLG HUHGGHYLFHSURFHGXUHUHODWHG

5HSRUWDEOHDGYHUVHHYHQWVVKDOOEHVXEPLWWHGWRWKH6SRQVRU DVVRRQDVSRVVLEOHDIWHUEHFRPLQJDZDUHRI
WKHHYHQW7KHVLWHVVKRXOGQRWLI\WKH6SRQVRURIUHSRUWDEOHDG YHUVHHYHQWVE\FUHDWLQJDQGVDYLQJWKH
DSSOLFDEOH&5)ZLWKLQWKHHOHFWU RQLFGDWDFDSWXUH('&V\VWHP $GGLWLRQDOLQIRUPDWLRQPD\EHUHTXHVWHG
E\WKH6SRQVRULQRUGHUWRVXSSRUWWKHUHSRUWLQJRI$(VWRUHJX ODWRU\DXWKRULWLHV$OODGYHUVHHYHQWVZLOOEH
UHSRUWHGDVSHUDSSOLFDEOHUHJXODWRU\UHTXLUHPHQWV 
6XEMHFW'HDWK 
6XEMHFWGHDWKVZLOOEHGRFXPHQ WHGDQGUHSRUWHGWRWKH6SRQVRUR QWKHDSSOLFDEOH&5)DVVRRQDVSRVVLEOH
DIWHUEHFRPLQJDZDUHRIWKHHYHQW,WLVWKHLQYHVWLJDWRUÂ¶VUHV SRQVLELOLW\WRQRWLI\WKH,5%(&RIWKHGHDWK
UHSRUWHGWR6SRQVRULQDFFRUGDQFHZL WKQDWLRQDODQGORFDOODZV DQGUHJXODWLRQV
6KRXOGDGHDWKRFFXUWKHLQYHV WLJDWRULVUHTXHVWHGWRUHFRUGG HDWKLQIRUPDWLRQLQWKHKRVSLWDOUHFRUGVDQG
LPPHGLDWHO\GRFXPHQWWKHLQIRUPDWLRQRQWKH'HDWK&5)DQGVXEPL WWR6SRQVRUWKURXJKWKHHOHFWURQLF
GDWDFDSWXUH('&V\VWHPGHSOR\HGE\$EERWW

 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

x $OOHIIRUWVWRREWDLQWKHGHWDLOVDERXWWKHFLUFXPVWDQFHVVXUU RXQGLQJWKHSDWLHQWGHDWKVKRXOG
EHPDGHE\WKH,QYHVWLJDWRU
x ,IDGHDWKHYHQWLVDQRXWFRPH RIDQDGYHUVHHYHQWDQ$(&5) PXVWEHFRPSOHWHGLQDGGLWLRQ
WRWKH'HDWK&5)
7KHVXEMHFWÂ¶VGHDWKLVDQHDUO\FRQFOXVLRQRIWKHVXEMHFWÂ¶VSDU WLFLSDWLRQLQWKH FOLQLFDOLQYHVWLJDWLRQ
7KHUHIRUHWKH,QYHVWLJDWRULVUH TXHVWHGWRFRPSOHWHWKH:LWKGU DZDOIRUP
 &RPSODLQWV'HYLFH'HILFLHQFLHV
'XULQJWKHVWXG\WKHLQYHVWLJDW RUZLOOEHUHVSRQVLEOHIRUUHSR UWLQJDOOFRPSODLQWVG HYLFHGHILFLHQFLHV
$FRPSODLQWLVGHILQHGDVDQ\ZULWWHQHOHFWURQLFRURUDOFRPPX QLFDWLRQWKDWDOOHJHVGHILFLHQFLHVUHODWHGWR
WKHLGHQWLW\TXDOLW\GXUDELOLW\UHOLDELOLW\VDIHW\HIIHFWL YHQHVVRUSHUIRUPDQFHRIDGHYLFHDIWHULWLVUHOHDVHG
IRUGLVWULEXWLRQ$GHYLFHGHILFLHQF\''LVGHILQHGDVDQLQDGHTXDF\RIDPHGLF DOGHYLFHZLWKUHVSHFWWRLWVLGHQWLW\TXDOLW\
GXUDELOLW\UHOLDELOLW\VDIHW\RUSHUIRUPDQFH,IWKHFRPSODLQW''GRHVQRWLQYROYHDQ$(WKHLQYHVWLJDWRUPX VWQRWLI\WKH$EERWW3RVW0DUNHW6XUYHLOODQFH
'HSDUWPHQWE\VXEPLWWLQJWKHFRPSODLQWLQIRUPDWLRQYLDHPDLOWR &&RRUGLQDWRUV#VMPFRPRUE\SKRQH
 DVVRRQDVSRVVLEOHDIWHUEHFRPL QJDZDUHRIWKHFRPSODLQW
&RPSODLQWV''VLQIRUPDWLRQZLOOQRWEHFROOHFWHGRQD&5)IRUW KHVWXG\
,IWKHFRPSODLQW''LQYROYHVDQ$(WKHLQYHVWLJDWRUPXVWFRPSO HWHDQ$(WKURXJKWKH('&V\VWHP
LQFOXGLQJWKHLQIRUPDWLRQRQWKHFRPSODLQWDQGVXEPLWWR$EERWW DVVRRQDVSRVVLEOH
 6RXUFHUHFRUGV
6RXUFHGRFXPHQWVZLOOEHFUHDWHG DQGPDLQWDLQHGE\WKHLQYHVWLJ DWLRQDOVLWHWHDPWKURXJKRXWWKHFOLQLFDO
LQYHVWLJDWLRQ7KHGDWDUHSRUWHGRQWKH&5)VZLOOEHGHULYHGIU RPDQGEHFRQVLVWHQ WZLWKWKHVHVRXUFH
GRFXPHQWVDQGDQ\GL VFUHSDQFLHVZLOOEHH[SODLQHGLQZULWLQJ
 5HFRUGV5HWHQWLRQ
7KH6SRQVRUDQGWKH3ULQFLSDO,QYHVWLJDWRUVZLOOPDLQWDLQWKHF OLQLFDOLQYHVWLJDWLRQGRFXPHQWVDVUHTXLUHG
0HDVXUHVZLOOEHWDNHQWRSUHYHQWDFFLGHQWDORUSUHPDWXUHGHVWU XFWLRQRIWKHVHGRFXPHQWV7KH3ULQFLSDO
,QYHVWLJDWRURUWKH6SRQVRUPD\WUDQVIHUFXVWRG\RIUHFRUGVWR DQRWKHUSHUVRQSDUW\DQGGRFXPHQWWKH
WUDQVIHUDWWKHLQYHVWLJDWLRQDOVLWHRUWKH6SRQVRUÂ¶VIDFLOLW\ DVDSSURSULDWH
7KHVHGRFXPHQWVPXVWEHUHWDLQHGE\WKHLQYHVWLJDWLRQDOVLWHIR UDSHULRGRI\HDUVDIWHUWKHFRQFOXVLRQ
RIWKHFOLQLFDOLQYHVWLJDWLRQDQGPDGHDYDLODEOHIRUPRQLWRULQJ RUDXGLWLQJE\WKH6SRQVRUÂ¶VUHSUHVHQWDWLYH
RUUHSUHVHQWDWLYHVRIWKHDSSOLFDEOHUHJXODWRU\DJHQFLHV

$OORULJLQDOVRXUFHGRFXPHQWVPXVWEHVWRUHGIRUWKHPD[LPXPWL PHUHTXLUHGE\WKHUHJXODWLRQVDWWKH
KRVSLWDOUHVHDUFKLQVWLWXWHRUSUDFWLFH LQ TXHVWLRQ,I RULJL QDOVRXUFHGRFXPHQWV FDQ QR ORQJHUEH
PDLQWDLQHGDWWKHVLWHWKHLQYH VWLJDWRUZLOOQRWLI\WKH6SRQVR U
 &OLQLFDO'DWD+DQGOLQJ
7KH6SRQVRUZLOOEHUHVSRQVLEOH IRUWKHGDWDKDQGOLQJ7KH6SRQ VRUDQGRULWVDIILOLDWHVZLOOEHUHVSRQVLEOH
IRUFRPSLOLQJDQGVXEPLWWLQJDOOUHTXLUHGUHSRUWVWRJRYHUQPHQW DODJHQFLHV'DWDZLOOEHDQDO\]HGE\WKH
6SRQVRUDQGPD\ EHWUDQVIHUUHG WRWKH6SRQVRUÂ¶VORFDWLRQV ZRUOG ZLGHDQGRUDQ\ RWKHU ZRUOGZLGH
UHJXODWRU\DXWKRULW\LQVXSSRUWRIDPDUNHWDSSURYDODSSOLFDWLR Q
 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

 3URWHFWLRQRI3HUVRQDOO\,G HQWLILDEOH,QIRUPDWLRQ
$EERWWUHVSHFWVDQGSURWHFWVSHUV RQDOO\LGHQWLILDEOHLQIRUPDWLR QFROOHFWHGRUPDLQWDLQHGIRUWKLVFOLQLFDO
LQYHVWLJDWLRQ7KHSULYDF\RIHDF KVXEMHFWDQGFRQILGHQWLDOLW\ RIKLVKHULQIRUPDWLRQZLOOEHSUHVHUYHGLQ
UHSRUWVDQGZKHQSXEOLVKLQJDQ\ GDWD&RQILGHQWLDOLW\RIGDWDZ LOOEHREVHUYHGE\DOOSDUWLHVLQYROYHGDWDOO
WLPHVWKURXJKRXWWKHFOLQLFDOLQYHVWLJDWLRQ$OOGDWDZLOOEHV HFXUHGDJDLQVWXQDXWKRUL]HGDFFHVV
 'DWD0DQDJHPHQW3ODQ
$'DWD0DQDJHPHQW3ODQ'03ZLOOGHVFULEHSURFHGXUHVXVHGIRU GDWDUHYLHZGDWDEDVHFOHDQLQJDQG
LVVXLQJDQGUHVROYLQJGDWDTX HULHV,IDSSURSULDWHWKH'03PD\ EHXSGDWHGWKURXJKRXWWKHFOLQLFDO
LQYHVWLJDWLRQGXUDWLRQ$OOUHYL VLRQVZLOOEHWUD FNHGDQGGRFXP HQWFRQWUROOHG

6XEMHFWGDWDZLOOEHFDSWXUHGLQDYDOLGDWHGHOHFWURQLFGDWDFD SWXUH('&V\VWHPKRVWHGE\WKH6SRQVRU
2QO\DXWKRUL]HGVLWHSHUVRQQHOZ LOOEHSHUPLWWHGWRHQWHUWKH& 5)GDWDWKURXJKWKH('&V\VWHPGHSOR\HG
E\$EERWW$QHOHFWURQLFDXGLWWUDLOZLOOEHXVHGWRWUDFNDQ\ VXEVHTXHQWFKDQJHVRIWKHHQWHUHGGDWD
 'RFXPHQWDQG' DWD&RQWURO
 7UDFHDELOLW\RI'RFXPHQWVDQG'DWD
7KHLQYHVWLJDWRUZLOOHQVXUHDFFXUDF\FRPSOHWHQHVVOHJLELOLW\ DQGWLPHOLQHVVRIWKHGDWDUHSRUWHGWRWKH
6SRQVRURQWKH&5)VDQGLQDOOUHTXLUHGUHSRUWV
 5HFRUGLQJ'DWD
7KH&5)ZLOOEHUHYLHZHGE\WKHDXWKRUL]HGVLWHSHUVRQQHO$QD SSURSULDWHFRPPHQWZLOOEHSURYLGHGWR
H[SODLQFKDQJHVWRGDWDUHSRUWHGRQWKH&5)
 0RQLWRULQJ
,WLVWKHUHVSRQVLELOLW\RIWKH 6SRQVRUWRHQVXUHWKHFOLQLFDO LQYHVWLJDWLRQLVFRQGXFWHGUHFRUGHGDQGUHSRUWHG
DFFRUGLQJ WR WKH DSSURYHG &,3 VXE VHTXHQW DPHQGPHQWV DSSOLFD EOH UHJXODWLRQV DQG JXLGDQFH
GRFXPHQWV0RQLWRULQJZLOOEHFRQGXFWHGDFFRUGLQJWR$EERWWÂ¶V&OLQLFDO0RQ LWRULQJZRUNLQVWUXFWLRQ
3ULRUWREHJLQQLQJWKHFOLQLFDOLQYHVWLJDWLRQWKH6SRQVRUZLOO FRQWDFWWKHLQYHVWLJDWRU RUGHVLJQHHWRGLVFXVV
WKHFOLQLFDOLQYHVWLJDWLRQDQGG DWDUHTXLUHPHQWV$GHVLJQDWHG PRQLWRUZLOOSHULRGLFDOO\UHYLHZWKHVXEMHFW
UHFRUGVDQGDVVRFLDWHGVRXUFHGRFXPHQWV7KHLQYHVWLJDWRUVKDOO PDNHVXEMHFWDQGFOLQLFDOLQYHVWLJDWLRQ
UHFRUGVDYDLODEOHWRWKHFOLQLFDOPRQLWRUIRUPRQLWRULQJ&HQWUDOL]HGPRQLWRULQJZLOORFFXUWKURXJKURXWLQHLQWHUQDOGDWD UHYLHZ7KLVPRQLWRULQJLVGHVLJQHGWRLGHQWLI\
PLVVLQJDQGLQFRQVLVWHQWGDWDGDWDRXWOLHUVDQGSRWHQWLDO&,3 GHYLDWLRQVWKDWPD\EHLQGLFDWLYHRIVLWHQRQ
FRPSOLDQFH2QVLWHPRQLWRULQJ PD\RFFXUDWWKHGLVFUHWLRQRIW KH6SRQVRU 
 &RPSOLDQFH6WDWHPHQW
 6WDWHPHQWRI&RPSOLDQFH
7KLVFOLQLFDOLQYHVWLJDWLRQZLOOEHFRQGXFWHGLQFRPSOLDQFHZLW KWKHPRVWFXUUHQWUHJLRQDODQGORFDOODZVDQG
UHJXODWLRQV3ULQFLSOHVRI*RRG&OLQLFDO3UDFWLFHZLOOEHIROOR ZHGDVEDVHGRQWKHPRVWFXUUHQWYHUVLRQRI
WKH:RUOG0HGLFDO$VVRFLDWLRQ: 0$'HFODUDWLRQRI+HOVLQNL

 6WXG\'RFXPHQW1R6-0&,39HU>&@ 
6WXG\1DPH'(/,9(5<
&OLQLFDO,QYHVWLJDWLRQ3ODQ

7KLVFRQILGHQWLDOGRFXPHQWLVWKHSURSHUW\RI$EERWWDQGVKDOO QRWEHUHSURGXFHGGLVWULEXWHGGLVFORVHGRUXVHGZLWKRXWWKH
H[SUHVVZULWWHQFRQVHQWRI$EERWW 
B&,37HPSODWHB5HYB&  3DJHRI
>5('$&7('@ 

7KHLQYHVWLJDWRUZLOOVLJQD&OLQLFDO7ULDO$JUHHPHQWDQGDJUHH VWREHFRPSOLDQWZLWKLW7KHLQYHVWLJDWRUZLOO
QRWVWDUWHQUROOLQJSDWLHQWVRUUH TXHVWLQJLQIRUPHGFRQVHQWIUR PDQ\SDWLHQWSULRUWRREWDLQLQJ,5%(&
DSSURYDODQGUHOHYDQW5HJXODWRU\$XWKRULW\DSSURYDOLIDSSOLFD EOHDQGDXWKRUL]DWLRQIURPWKH6SRQVRULQ
ZULWLQJIRUWKHFOLQLFDOLQYHVWLJDWLRQ ,IDGGLWLRQDOUHTXLUHPHQWVDUHLPSRVHGE\WKH,5%(&RUUHOHYDQW
5HJXODWRU\$XWKRULW\WKRVHUHTXLUHPHQWVZLOOEHIROORZHG,ID Q\DFWLRQLVWDNHQE\DQ,5%(&RUDUHOHYDQW
5HJXODWRU\$XWKRULW\ZLWKUHVSHFWWRWKHFOLQLFDOLQYHVWLJDWLRQ WKDWLQIRUPDWLRQZLOOEHIRUZDUGHGWRWKH
6SRQVRU

$VWKH6SRQVRU$EERWWKDVWDNHQ XSJHQHUDOOLDELOLW\LQVXUDQFH LQDFFRUGDQFHZLWKWKHUHTXLUHPHQWVRIWKH
DSSOLFDEOHORFDOODZV$QDSSURSULDWH$EERWWFRXQWU\UHSUHVHQWD WLYHZLOOEHXWLOL]HGWRXQGHUVWDQGWKH
UHTXLUHPHQWVIRUWKHW\SHRILQVXUDQFHWKDWZLOOEHSURYLGHGIR UVXEMHFWVDQGVXFKLQIRUPDWLRQZLOOEH
LQFRUSRUDWHGLQWRWKHVLWHLQIRUPHGFRQVHQWDVDSSOLFDEOH,I UHTXLUHGDGGLWLRQDOVXEMHFWFRYHUDJHRUD
FOLQLFDOLQYHVWLJDWL RQVSHFLILFLQVXUDQFHZLOOEHSURYLGHGE\W KH6SRQVRU
 4XDOLW\$VVXUDQFH$XGLWV DQG5HJXODWRU\ ,QVSHFWLRQV
7KHLQYHVWLJDWRUDQGRUGHOHJDWHVKRXOGFRQWDFWWKH6SRQVRULPP HGLDWHO\XSRQQRWLILF DWLRQRIDUHJXODWRU\
DXWKRULW\LQVSHFWLRQDWWKHVLWH $PRQLWRURUGHVLJQHHZLOODV VLVWWKHLQYHVWLJDWRUDQGRUGHOHJDWHLQ
SUHSDULQJIRUWKHDXGLW7KH6SRQV RUPD\SHUIRUPTXDOLW\DVVXUD QFHDXGLWVDVUHTXLUHG
7KH3ULQFLSDO,QYHVWLJDWRURULQVWLWXWLRQZLOOSURYLGHGLUHFWD FFHVVWRVRXUFHGDWDGXULQJDQGDIWHUWKHFOLQLFDO
LQYHVWLJDWLRQIRUPRQLWRULQJDXGLWV,5%(&UHYLHZDQGUHJXODW RU\DXWKRULW\LQVSHFWLRQVDVUHTXLUHG7KH
3ULQFLSDO,QYHVWLJDWRURULQVWLWXWLRQZLOOREWDLQSHUPLVVLRQIR UGLUHFWDFFHVVWRVRXUFHGRFXPHQWVIURPWKH
VXEMHFWKRVSLWDODGPLQLVWUDWLRQDQGQDWLRQDOUHJXODWRU\DXWKRU LWLHVEHIRUHVWDUWLQJWKHFOLQLFDOLQYHVWLJDWLRQ
 5HSHDWHGDQG6HULRXV1RQ&RPSOLDQFH
,QWKHHYHQWRIUHSHDWHGQRQFRPSOLDQFHRUDRQHWLPHVHULRXVQ RQFRPSOLDQFHDVGHWHUPLQHGE\WKH
6SRQVRUDPRQLWRURUGHVLJQHHZ LOODWWHPSWWRVHFXUHFRPSOLDQF HE\RQHRUPRUHRIWKHIROORZLQJDFWLRQV
x 9LVLWLQJWKHLQYHVWLJDWRU
x &RQWDFWLQJWKHLQYHVWLJDWRUE\WHOHSKRQH
x &RQWDFWLQJWKHLQYHVWLJDWRULQZULWLQJ
x 5HWUDLQLQJRIWKHLQYHVWLJDWRU

,IDQLQYHVWLJDWRULVIRXQGWREHUHSHDWHGO\QRQFRPSOLDQWZLWK WKHVLJQHGDJUHHPHQWWKH&,3RUDQ\RWKHU
FRQGLWLRQVRIWKHFOLQLFDOLQYHVWLJDWLRQWKH6SRQVRUZLOOHLWK HUVHFXUHFRPSOLDQFHRUDWLWVVROHGLVFUHWLRQ
WHUPLQDWHWKHLQYHVWLJDWRUÂ¶VSDUW LFLSDWLRQLQWKHFOLQLFDOLQYH VWLJDWLRQ,QFDVHRIWHUPLQDWLRQWKH6SRQVRUZLOO
LQIRUPWKHUHVSRQVLEOHUHJXODWRU\DXWKRULW\DVUHTXLUHGDQGH QVXUHWKDWWKH,5%(&LVQRWLILHGHLWKHUE\
WKH3ULQFLSDO,QYHVWLJDWRURUE\WKH6SRQVRU
 6XVSHQVLRQRU3UHPDWXUH7H UPLQDWLRQRIWKH&OLQLFDO,QYHVWLJ DWLRQ
7KH6SRQVRUUHVHUYHVWKHULJKWWRWHUPLQDWHWKHFOLQLFDOLQYHVW LJDWLRQDWDQ\VWDJHZLWKDSSURSULDWHZULWWHQ
QRWLFHWRWKHLQYHVWLJDWRUV,5% (&VDQGUHOHYDQW5HJXODWRU\DX WKRULWLHVLIUHTXLUHG
$3ULQFLSDO,QYHVWLJDWRU,5%(&RUUHJXODWRU\DXWKRULW\PD\VX VSHQGRUSUHPDWXUHO\WHUPLQDWHSDUWLFLSDWLRQ
LQDFOLQLFDOLQYHVWLJDWLRQDWWKHLQYHVWLJDWLRQDOVLWHVIRUZK LFKWKH\DUHUHVSRQVLEOH7KHLQYHVWLJDWRUVZLOO
IROORZWKHUHTXLUHPHQWVVSHFLI LHGLQWKH&OLQLFDO7ULDO$JUHHPH QW
,IVXVSLFLRQRIDQXQDFFHSWDEOH ULVNWRVXEMHFWV DULVHVGXULQJ WKHFOLQLFDOLQYHVWLJDWLRQRUZKHQVRLQVWUXFWHG
E\WKH,5%(&RUUHJXODWRU\DXWK RULW\WKH6SRQVRUPD\VXVSHQG WKHFOLQLFDOLQYHVWLJDWLRQZKLOHWKHULVNLV
DVVHVVHG7KH6SRQVRUZLOOWHUPLQDWHWKHFOLQLFDOLQYHVWLJDWLRQ LIDQXQDFFHSWDEOHULVNLVFRQILUPHG,IWKH
6SRQVRUFRPSOHWHVDQDQDO\VLVRI WKHUHDVRQVIRUWKHVXVSHQVLRQ LPSOHPHQWVWKHQHFHVVDU\FRUUHFWLYH
DFWLRQVDQGGHFLGHVWROLIWWKHWHPSRUDU\VXVSHQVLRQWKH6SRQ VRUZLOOLQIRUPWKH3ULQFLSDO,QYHVWLJDWRUV
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 32 of 39 
                                             [REDACTED]   
 
IRB/EC, or regulatory authority, where appropriate, of the rationale, providing them with the relevant data 
supporting this decision. Approval from the IRB/EC or regulatory authority, where appropr iate, will be 
obtained before the clinical investigation resumes. If subjects have been informed of the suspension, the 
Principal Investigator or authorized designee will inform them of the reasons for resumption.  
 
If the Sponsor suspends or prematurely te rminates the clinical investigation at an individual investigational 
site in the interest of safety, the Sponsor will inform all other Principal Investigators.  
 
If suspension or premature termination occurs, the Sponsor will remain responsible for providing resources 
to fulfill the obligations from the CIP and existing agreements for following up the subjects enrolled in the 
clinical investigation, and the Principal Investigator or authorized designee will promptly inform the enrolled 
subjects at hi s/her investigational site, if appropriate.  
13 Clinical Investigation Conclusion  
The clinical investigation will be concluded when:  
â€¢ All sites are closed AND  
â€¢ The final report has been provided to investigators or the Sponsor has provided formal 
documentation o f clinical investigation closure.  
14 Publication Policy  
Publications or presentations of clinical investigation methods or results will adhere to Abbott â€™s publication 
policy, which is based on Good Publication Practices and International Committee of Medical Journal 
Editors (ICMJE) guidelines. A copy of the policy will be provided  upon request of the investigator . 
Publication planning and authorship determinations will be overseen by the Steering Committee or 
Publications Committee , and investigators will be n otified via email about the dissemination of study data 
and opportunities for involvement as authors on publications/presentations.   
15 Reporting Results on ClincalTrials.gov Website   
This clinical investigation  will be reg istered on ClinicalTrials.gov. A full report of the pre -specified 
outcomes, regardless of the results , will be made public through the ClinicalTrials.gov website .  
 
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 33 of 39 
                                             [REDACTED]   
 
16 Appendix  A: CIP Revisions  
 
Procedure for CIP Amendments  
 
This CIP may be amended as appropriate by the Sponsor . Rationale  will be included with each amended 
version in the revision h istory table below . The version number and date of amendments will be 
documented.  
 
The acknowledgement of the amended CIP  by the Principal Investigators will be collected on the 
signature pages . 
 
IRB/EC and r elevant R egulatory A uthorities , if applicable,  will be no tified of amendments to the CIP.  
 
Revision History  
Amendment 
Number  Version  Date  Rationale  Details  
Not 
Applicable  VB 12JUN2016  First release of 
CIP NA 
1 VC 21JUN2017  Amendment  Substantial Amendment  
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 34 of 39 
                                             [REDACTED]   
 
17 Appendix  B: Definitions  
 
Non-study Specific Definitions  
 
Adverse Event (AE)  
Any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including 
abnormal laboratory findings) in subjects, users or other persons, whether or not related to the medical 
device under clinical investigation . 
 
This definit ion includes events related to the medical device or the comparator.  
This definition includes events related to the procedures involved.  
 
Serious Adverse Event (SAE)  
An adverse event that led to:  
â€¢ Death  
â€¢ A serious deterioration in the health of the subject, that either resulted in:  
o A life -threatening illness or injury OR  
o A permanent impairment to  a body structure or a body function OR  
o An in -patient or prolonged hospitalization OR  
o A medical or surgical intervention to prevent life -threatening illness or injury  or permanent 
impairment to a body structure or a body function OR 
o A malignant tumor  (only for specific countries)  
â€¢ Fetal distress, fetal death or a congenital abnormality or birth defect  
 
A planned hospitalization for a pre -existing condition, or a procedu re required by the CIP is not considered 
a serious adverse event.  
 
Adverse Device Effect (ADE)  
An adverse event related to the use of a medical device.  
 
This definition includes adverse events resulting from insufficient or inadequate instructions for use,  
deployment, implantation, installation, or operation, or any malfunction of the medical device.  
 
This definition includes any event resulting from the use error or from intentional misuse of the medical 
device.  
 
Serious Adverse Device Effect (SADE)  
Adverse device effect that has resulted in any of the consequences characteristic of a serious adverse 
event.  
 
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 35 of 39 
                                             [REDACTED]   
 
18 Appendix  C: BurstDR Programming Guidelines  
 
BurstDR Programming:  
 
1. Prior to programming:  
â€¢ Limit distractions by using a quiet location.  
â€¢ Have the subject lie on their back.  
â€¢ Explain to the subject that a sensation is any sort of change felt, such as warmth, 
heaviness, pressure, tingling, etc.  
 
2. Establish paresthesia coverage using standard tonic stimulation.  
â€¢ It is advised to find coverage in a single stimset (area)  with a simple array.  
â€¢ This can lead to reduced amplitude requirements.  
Note:  The intent is to confirm coverage of entire/all pain areas, which may require higher 
than comfortable stimulation levels in certain spots.  
 
3. If multiple stimsets  were required to fully cover the subjectâ€™s pain, combine all areas into a single 
stimset (area) . To combine areas, copy all cathodes (negative) and then fill anodes (positive) 
into remaining contacts that were utilized across tonic stimulation stimsets.  
 
Note: Test combined configuration with tonic to ensure combination of stimsets resulted in no 
unexpected coverage changes.  
 
4. Enable Burst mode.  
Do not change the burst -rate (40 Hz), intraburst -rate (500 Hz) and PW (1000 Âµs). 
 
5. Slowly ramp amplitude upwards b y 0.05 mA until subject experiences any sensation (pressure, 
heat, etc.).  
 
6. Slowly decrease amplitude until sensation disappears.  
 
7. Note the amplitude value and confirm value by repeating steps 5 and 6.  
 
8. Reduce amplitude by 40% . Set this as your Target Ampli tude . 
 
9. Adjust the Maximum Amplitude for the Patient Controller settings to the lowest possible value that 
is still above your Target.  
 
10. At this point, consider whether cycling can be used to improve longevity . Start with 5 seconds on 
15 seconds off . If furt her optimization is needed, change to 5 seconds on 5 seconds off.  
 
Note: If the subject feels the need to adjust therapy after the initial programming, advise them to 
adjust their amplitude by one click and allow time to assess the change before making add itional 
adjustments . If multiple adjustments are needed, schedule the subject for a reprogramming 
session to determine new, ideal amplitude settings.  
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 36 of 39 
                                             [REDACTED]   
 
19 Appendix  D: Imaging Guidelines  
 
At time of trial implant:  
At the end of the intraoperative lead placement procedure, including anchoring procedure , a â€œat time of trial 
implant imageâ€ will be saved with the fluoroscope . The investigator should align the vertebral endplates (in 
an AP view) and be certain to include the thoracic/lumbar junction in the i mage, such that the vertebral level 
of the lead is easily countable/verifiable . A lateral image should also be saved . The images should be 
printed out and saved with the CRF . If the images cannot be printed directly, they may be screen shot with 
an iPad (o r equivalent) and printed later . The level of the lead tip and proximal contact will be noted on the 
Case Report Form (CRF) .  
End of trial evaluation period:  
At the End of I nitial Trial Evaluation Period study visit and the End of Extended  Trial Evaluation  Period study 
visit (if applicable), the patient should have another fluoroscopic image taken as above. The image should 
be printed out as above. The image level and patient position (standing vs. sitting) should be noted by the 
investigator and recorded on the CRF.  
 
Alternate acceptable end of trial evaluation period radiograph procedure for clinics without a 
fluoroscope in/near clinic (US):   At the end of the initial trial evaluation period study visit and the 
extended evaluation period study visit (if a pplicable), the patient will have a thoraco -lumbar AP/LAT set 
of spinal plain radiographs done at an imaging facility and printed onto a DVD. That DVD will be viewed 
and read by the investigator, recording the end of trial evaluation period lead location o n the CRF. The 
DVD will be kept with the subjects research file.  
 
Alternate acceptable end of trial evaluation period radiograph procedure for clinics without a 
fluoroscope in/near clinic (OUS):   At the end of the initial trial evaluation period study visi t or the 
extended evaluation period study visit (if applicable), the patient will have a thoraco -lumbar AP/LAT 
set of spinal plain radiographs done at an imaging facility and printed onto a DVD or provided in pdf 
form for upload. If an imaging facility is not available, the radiographs can be taken on the OR/suite x -
ray machine provided that a printout can be collected for upload. That DVD/PDF will be viewed and 
read by the investigator , recording the end of trial evaluation period lead location on the CRF . The 
DVD/PDF will be kept with the subjects research file.  
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 37 of 39 
                                             [REDACTED]   
 
20 Appendix E: Bibliography  
 
1. Taylor RS. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back 
and leg pain/failed back surgery syndrome: Results of a systematic  review and meta -analysis. J Pain 
Symp Mgmt, 2006; 31(4S):S13 -S19. 
 
2. Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook 
K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson  T, Turk D, Von 
Korff M, Weiner DK. Report of the NIH Task Force on research standards for chronic low back pain. J 
Pain. 2014 Jun;15(6):569 -85. 
 
3. Huang KT, et.al. A national survey of spinal cord stimulation trial -to-permanent conversion rates. 
Neuromodula tion, 2014; Neuromodulation, 2015;18(2):133 -9. 
 
4. Deyo RA, Ramsay K, Buckley DI, Michales L, Kobus A, Eckstorm E, Forro V, Morris C. Performance 
of a patient reported outcomes measurement information system (promis) short form in older adults 
with chronic mu sculoskeletal pain. Pain Medicine 2016; 17: 314 â€“324. 
 
5. Rosenberg J, et. al. Spinal cord stimulation provides pain relief with improved psychosocial function:  
results from EMP3OWER. Pain Medicine, 2016; 17: 2311 â€“2325.  
 
 
 
 
 
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 38 of 39 
                                             [REDACTED]   
 
21 Appendix F: Case Report Form  
A sample Case Report Form will be kept under a separate cover and is available upon request.  
 
  
 Study Document No: SJM -CIP-10116 Ver . [C] 
Study Name: DELIVERY  
 Clinical Investigation  Plan 
 
This confidential document is the property of Abbott  and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott . 
86357_CIP Template_Rev_ C Page 39 of 39 
                                             [REDACTED]   
 
22 Appendix G: Informed Consent Form  
A sample Informed Consent will be kept under a separate cover and is available upon request.  
 
 
 
 